这是一篇来自已证抗体库的有关人类 CD1D的综述，是根据450篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CD1D 抗体。
CD1D 同义词: CD1A; R3; R3G1

艾博抗（上海）贸易有限公司
小鼠 单克隆（F7.2.38）
  • 免疫组化; 人类; 图 7c
艾博抗（上海）贸易有限公司 CD1D抗体（Abcam, ab17143)被用于被用于免疫组化在人类样本上 (图 7c). Mol Ther Oncolytics (2022) ncbi
小鼠 单克隆（NOR3.2 (NOR3.2/13.17)）
  • 免疫组化-石蜡切片; 人类; 1:300; 图 2b
艾博抗（上海）贸易有限公司 CD1D抗体（Abcam, NOR3.2)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:300 (图 2b). BMC Cancer (2019) ncbi
小鼠 单克隆（F7.2.38）
  • 免疫组化-石蜡切片; 人类; 图 4c
艾博抗（上海）贸易有限公司 CD1D抗体（Abcam, ab17143)被用于被用于免疫组化-石蜡切片在人类样本上 (图 4c). Neurosurgery (2018) ncbi
小鼠 单克隆（F7.2.38）
  • 免疫组化-石蜡切片; 小鼠; 图 9
艾博抗（上海）贸易有限公司 CD1D抗体（Abcam, ab17143)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 9). PLoS ONE (2016) ncbi
小鼠 单克隆（NOR3.2 (NOR3.2/13.17)）
  • 免疫组化-石蜡切片; 人类; 1:100
艾博抗（上海）贸易有限公司 CD1D抗体（Abcam, Ab11076)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. J Transl Med (2013) ncbi
BioLegend
小鼠 单克隆（51.1）
  • mass cytometry; 人类; 500 ug/ml; 图 s11a
BioLegend CD1D抗体（Biolegend, 51.1)被用于被用于mass cytometry在人类样本上浓度为500 ug/ml (图 s11a). Nature (2020) ncbi
小鼠 单克隆（51.1）
  • 流式细胞仪; 人类; 图 1b
BioLegend CD1D抗体（BioLegend, 51.1)被用于被用于流式细胞仪在人类样本上 (图 1b). Sci Rep (2019) ncbi
小鼠 单克隆（51.1）
  • 流式细胞仪; 人类; 图 s4b
  • 免疫印迹; 人类; 图 s4b
BioLegend CD1D抗体（BioLegend, 51.1)被用于被用于流式细胞仪在人类样本上 (图 s4b) 和 被用于免疫印迹在人类样本上 (图 s4b). J Immunol (2018) ncbi
小鼠 单克隆（51.1）
  • 流式细胞仪; 人类
BioLegend CD1D抗体（Biolegend, 51.1)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2016) ncbi
赛默飞世尔
小鼠 单克隆（51.1）
  • 免疫沉淀; 人类
赛默飞世尔 CD1D抗体（eBiosciences, 51.1)被用于被用于免疫沉淀在人类样本上. Immunology (2013) ncbi
圣克鲁斯生物技术
小鼠 单克隆（C3D5）
  • 免疫细胞化学; 人类
  • 免疫印迹; 人类
圣克鲁斯生物技术 CD1D抗体（Santa Cruz, sc-19632)被用于被用于免疫细胞化学在人类样本上 和 被用于免疫印迹在人类样本上. Mol Cells (2013) ncbi
丹科医疗器械技术服务（上海）有限公司
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:250; 图 2a
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:250 (图 2a). Int J Mol Sci (2021) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; pigs ; 1:100; 图 8c, 8i, 8o
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在pigs 样本上浓度为1:100 (图 8c, 8i, 8o). Sci Rep (2021) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:100; 图 3a
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（DAKO, A0452)被用于被用于免疫组化在小鼠样本上浓度为1:100 (图 3a). Front Pharmacol (2021) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:200
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化在小鼠样本上浓度为1:200. Microorganisms (2021) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:200; 图 1b
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:200 (图 1b). Cell Mol Gastroenterol Hepatol (2021) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 图 4b
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, Agilent Technologies, A0452)被用于被用于免疫组化在小鼠样本上 (图 4b). Antioxidants (Basel) (2021) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 5e, s5b
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 5e, s5b). Blood (2021) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:150; 图 5
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:150 (图 5). Cancers (Basel) (2021) ncbi
domestic rabbit 多克隆
  • 免疫组化; 人类; 1:100; 图 s1
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化在人类样本上浓度为1:100 (图 s1). Nature (2021) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:300; 图 s4b
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:300 (图 s4b). Sci Rep (2021) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:500; 图 4c
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（DAKO, A0452)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:500 (图 4c). Front Immunol (2020) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:100; 图 3, 5
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化在小鼠样本上浓度为1:100 (图 3, 5). Nat Commun (2020) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 1:100; 图 1b
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 1b). Front Immunol (2019) ncbi
domestic rabbit 多克隆
  • 免疫组化-冰冻切片; 人类; 图 5d
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-冰冻切片在人类样本上 (图 5d). Nat Commun (2020) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:1000; 图 s5b, s5c, s5d
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:1000 (图 s5b, s5c, s5d). Nat Commun (2020) ncbi
domestic rabbit 多克隆
  • 免疫组化-冰冻切片; 小鼠; 图 s8d, s9b
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-冰冻切片在小鼠样本上 (图 s8d, s9b). BMC Immunol (2019) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 图 s5a
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在人类样本上 (图 s5a). Cell (2019) ncbi
domestic rabbit 多克隆
  • 免疫组化; 人类; 图 3c
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（DAKO, AO452)被用于被用于免疫组化在人类样本上 (图 3c). Cell (2019) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:500
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化在小鼠样本上浓度为1:500. elife (2019) ncbi
domestic rabbit 多克隆
  • 免疫组化-冰冻切片; 小鼠; 1:200
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:200. elife (2019) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 2a
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, AD452)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 2a). Sci Rep (2018) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 1:100; 图 2a
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（DAKO, A0452)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 2a). Cell Death Dis (2018) ncbi
domestic rabbit 多克隆
  • 免疫组化-冰冻切片; 人类; 表 s1
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-冰冻切片在人类样本上 (表 s1). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化; 人类; 图 3b
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化在人类样本上 (图 3b). Oncotarget (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 5i
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（DAKO, A0452)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 5i). Cell Metab (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 1:100; 图 s1d
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 s1d). J Clin Invest (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 2a
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（DakoCytomation, A0452)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 2a). Oncoimmunology (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 6d
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 6d). Cell Death Dis (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:1000; 图 s1h
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（DAKO, A0452)被用于被用于免疫组化在小鼠样本上浓度为1:1000 (图 s1h). Nat Commun (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; African green monkey; 1 ug/ml; 图 2a
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在African green monkey样本上浓度为1 ug/ml (图 2a). J Immunol (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 1:400; 图 2c
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:400 (图 2c). Cancer Immunol Immunother (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 1:100
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Vet Pathol (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 猕猴; 1:100; 图 5
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（DakoCytomation, A0452)被用于被用于免疫组化-石蜡切片在猕猴样本上浓度为1:100 (图 5). J Neuroinflammation (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:1000; 图 6c
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:1000 (图 6c). Nat Cell Biol (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 1:800; 图 3
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:800 (图 3). J Transl Med (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 1:600; 图 3b
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:600 (图 3b). Oncol Lett (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 1:100; 图 2
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（DAKO, A0452)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 2). Cancer Discov (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 人类; 1.2 ug/ml; 图 3d
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化在人类样本上浓度为1.2 ug/ml (图 3d). Sci Transl Med (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 犬; 1:50; 图 5
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（DAKO, A0452)被用于被用于免疫组化-石蜡切片在犬样本上浓度为1:50 (图 5). J Vet Med Sci (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 犬; 1:50; 图 2
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在犬样本上浓度为1:50 (图 2). Vet Immunol Immunopathol (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 1:100; 图 1ab
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A452)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 1ab). Cancer Immunol Immunother (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 1:100; 图 4
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 4). Dis Model Mech (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 1:100; 图 1
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A452)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 1). PLoS ONE (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 国内马; 图 1a
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在国内马样本上 (图 1a). Peerj (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 家羊; 1:200; 图 s1
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（DAKO, A0452)被用于被用于免疫组化-石蜡切片在家羊样本上浓度为1:200 (图 s1). J Neuroinflammation (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:200; 图 4
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:200 (图 4). Int J Cancer (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 人类; 1:500; 图 3
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（DAKO, A04052)被用于被用于免疫组化在人类样本上浓度为1:500 (图 3). EMBO Mol Med (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 6
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A-0452)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 6). Am J Transplant (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-冰冻切片; 人类; 1:100; 图 1
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:100 (图 1). Nat Immunol (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 人类; 图 10c
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于被用于免疫组化在人类样本上 (图 10c). Gut (2016) ncbi
domestic rabbit 多克隆
丹科医疗器械技术服务（上海）有限公司 CD1D抗体（Dako, A0452)被用于. J Neuroimmune Pharmacol (2016) ncbi
Ventana
domestic rabbit 单克隆（2GV6）
  • 免疫组化-石蜡切片; 人类; 图 s14
Ventana CD1D抗体（Ventana, 790-4341)被用于被用于免疫组化-石蜡切片在人类样本上 (图 s14). J Clin Invest (2022) ncbi
domestic rabbit 单克隆（2GV6）
  • 免疫组化-石蜡切片; 人类; 图 2b
Ventana CD1D抗体（Ventana, 2GV6)被用于被用于免疫组化-石蜡切片在人类样本上 (图 2b). Front Cardiovasc Med (2021) ncbi
domestic rabbit 单克隆（2GV6）
  • 免疫组化-石蜡切片; 人类; 图 3a
Ventana CD1D抗体（Ventana, 26V6)被用于被用于免疫组化-石蜡切片在人类样本上 (图 3a). Cancers (Basel) (2021) ncbi
domestic rabbit 单克隆（2GV6）
  • 免疫组化-石蜡切片; 小鼠; 0.4 ug/ml; 图 3d
Ventana CD1D抗体（Ventana, 790-4341)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为0.4 ug/ml (图 3d). Cancer Res (2021) ncbi
domestic rabbit 单克隆（2GV6）
  • 免疫组化; 人类; 1:600
Ventana CD1D抗体（Ventana, 790-4341)被用于被用于免疫组化在人类样本上浓度为1:600. Ann Hematol (2021) ncbi
domestic rabbit 单克隆（2GV6）
  • 免疫组化; 人类; 图 3e
Ventana CD1D抗体（Ventana, 790-4341)被用于被用于免疫组化在人类样本上 (图 3e). Cell (2019) ncbi
domestic rabbit 单克隆（2GV6）
  • 免疫组化-石蜡切片; 人类; 图 s2
Ventana CD1D抗体（Ventana, 2GV6)被用于被用于免疫组化-石蜡切片在人类样本上 (图 s2). Clin Cancer Res (2016) ncbi
Cell Marque
domestic rabbit 单克隆（MRQ-39）
  • 免疫组化; 人类; 1:100; 图 1c
Cell Marque CD1D抗体（Cell Marque, MRQ-39)被用于被用于免疫组化在人类样本上浓度为1:100 (图 1c). Adv Sci (Weinh) (2021) ncbi
domestic rabbit 单克隆（MRQ-39）
  • 免疫组化-石蜡切片; 人类; 1:500; 图 3a
Cell Marque CD1D抗体（Cell Marque, MRQ-39)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:500 (图 3a). Br J Cancer (2016) ncbi
碧迪BD
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 1:50; 图 s5a
碧迪BD CD1D抗体（BD, 562280)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 s5a). Nat Commun (2022) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, 562280)被用于被用于流式细胞仪在人类样本上. J Immunother Cancer (2022) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 图 s2c
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在人类样本上 (图 s2c). Mol Cancer Ther (2022) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 1:100; 图 s1b
碧迪BD CD1D抗体（BD Pharmingen, 552852)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 s1b). Nat Commun (2022) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 2d
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 2d). Med Oncol (2022) ncbi
小鼠 单克隆（HIT3a）
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD1D抗体（BD Biosciences, 555342)被用于被用于流式细胞仪在人类样本上 (图 3a). Front Immunol (2022) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; ; 图 9a
碧迪BD CD1D抗体（BD Pharmingen, SP34-2)被用于被用于流式细胞仪在猕猴样本上浓度为 (图 9a). Front Immunol (2022) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 8a
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 8a). J Clin Invest (2022) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1d
碧迪BD CD1D抗体（BD Pharmingen, 560275)被用于被用于流式细胞仪在人类样本上 (图 1d). Oncoimmunology (2022) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 s7
碧迪BD CD1D抗体（BD Pharmingen, 555332)被用于被用于流式细胞仪在人类样本上 (图 s7). Oncoimmunology (2022) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 图 5e
碧迪BD CD1D抗体（BD Biosciences, 560352)被用于被用于流式细胞仪在人类样本上 (图 5e). Front Mol Biosci (2021) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 1:300; 图 6a
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上浓度为1:300 (图 6a). Nat Commun (2021) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 3c, 3d
碧迪BD CD1D抗体（BD Bioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 3c, 3d). J Immunother Cancer (2021) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, 555341)被用于被用于流式细胞仪在人类样本上. Cell (2021) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 小鼠; 1:1000
碧迪BD CD1D抗体（BD Biosciences, 560176)被用于被用于流式细胞仪在小鼠样本上浓度为1:1000. Cell Rep Med (2021) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 小鼠; 图 1e-1h
碧迪BD CD1D抗体（BD, SP34-2)被用于被用于流式细胞仪在小鼠样本上 (图 1e-1h). Adv Sci (Weinh) (2021) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD, 552852)被用于被用于流式细胞仪在人类样本上. Cell (2021) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 图 s2a
碧迪BD CD1D抗体（BD Biosciences, 557757)被用于被用于流式细胞仪在人类样本上 (图 s2a). Cell Rep Med (2021) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 2a). Int J Mol Sci (2021) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 1b
碧迪BD CD1D抗体（BD, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1b). Acta Neuropathol (2021) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 1:500
碧迪BD CD1D抗体（BD, 555332)被用于被用于流式细胞仪在人类样本上浓度为1:500. Cell (2021) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 1:1000; 图 s1d
碧迪BD CD1D抗体（BD Bioscience, 561027)被用于被用于流式细胞仪在人类样本上浓度为1:1000 (图 s1d). Cell (2021) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 1:200; 图 s1h
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 s1h). Nature (2021) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 4
碧迪BD CD1D抗体（BD Bioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 4). Aging Cell (2021) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 1:50; 图 3s2a
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 3s2a). elife (2020) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD1D抗体（BD, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 3a). BMC Cancer (2020) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 s2a
碧迪BD CD1D抗体（BD, 563725)被用于被用于流式细胞仪在人类样本上 (图 s2a). Cell (2021) ncbi
小鼠 单克隆（UCHT1）
  • 其他; 小鼠
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于其他在小鼠样本上. Nat Commun (2020) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD1D抗体（BD Biosciences, 552851/339186)被用于被用于流式细胞仪在人类样本上 (图 3a). elife (2020) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD1D抗体（BD Biosciences, 552851/339186)被用于被用于流式细胞仪在人类样本上 (图 3a). elife (2020) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, 563546)被用于被用于流式细胞仪在人类样本上. J Clin Invest (2020) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 1:100; 图 1f
碧迪BD CD1D抗体（BD, UCHT1)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 1f). elife (2020) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD1D抗体（BD, UCHT-1)被用于被用于流式细胞仪在人类样本上 (图 1a). Rheumatology (Oxford) (2020) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 2a). J Extracell Vesicles (2020) ncbi
小鼠 单克隆（UCHT1）
  • 抑制或激活实验; 人类; 1 ug/ml; 图 1d
碧迪BD CD1D抗体（BD Biosciences, 550368)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml (图 1d). elife (2020) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; African green monkey; 图 3c
碧迪BD CD1D抗体（BD Pharmingen, 560351)被用于被用于流式细胞仪在African green monkey样本上 (图 3c). PLoS Pathog (2020) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 s1a
碧迪BD CD1D抗体（BD Pharmingen, SK7)被用于被用于流式细胞仪在人类样本上 (图 s1a). Sci Adv (2020) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 s8
碧迪BD CD1D抗体（BD Biosciences, 561805)被用于被用于流式细胞仪在猕猴样本上 (图 s8). Nat Commun (2020) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 5c
碧迪BD CD1D抗体（BD Bioscience, 560365)被用于被用于流式细胞仪在人类样本上 (图 5c). Stem Cell Res Ther (2020) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1
碧迪BD CD1D抗体（BD, 347347)被用于被用于流式细胞仪在人类样本上 (图 1). J Cancer (2020) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 s3a
碧迪BD CD1D抗体（BD, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s3a). Science (2019) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 1:50; 图 4c
碧迪BD CD1D抗体（BD, 557851)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 4c). Nature (2019) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 图 13
碧迪BD CD1D抗体（BD Biosciences, 552127)被用于被用于流式细胞仪在人类样本上 (图 13). Hum Vaccin Immunother (2020) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 3d
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 3d). Nature (2019) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 1:200; 图 1s1a
碧迪BD CD1D抗体（BD Pharmagen, 340440)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 1s1a). elife (2019) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 s5
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在猕猴样本上 (图 s5). Science (2019) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 1:1000; 图 4d
碧迪BD CD1D抗体（BD, SK7)被用于被用于流式细胞仪在人类样本上浓度为1:1000 (图 4d). PLoS Pathog (2019) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 3
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 3). Sci Rep (2019) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 1:66; 图 1e
碧迪BD CD1D抗体（BD pharmigen, 557943)被用于被用于流式细胞仪在人类样本上浓度为1:66 (图 1e). elife (2019) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 1:20; 图 5k, s22c
碧迪BD CD1D抗体（BD Biosciences, 561416)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 5k, s22c). Nat Commun (2019) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 图 2b
碧迪BD CD1D抗体（BD, 558124)被用于被用于流式细胞仪在人类样本上 (图 2b). Cell (2019) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 s1
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s1). JCI Insight (2019) ncbi
小鼠 单克隆（SK7）
  • 免疫组化-冰冻切片; 人类; 1:100; 图 s3a
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:100 (图 s3a). J Invest Dermatol (2019) ncbi
小鼠 单克隆（UCHT1）
  • mass cytometry; 人类; 图 s1
碧迪BD CD1D抗体（BD, UCHT1)被用于被用于mass cytometry在人类样本上 (图 s1). J Exp Med (2019) ncbi
小鼠 单克隆（UCHT1）
  • 免疫组化-冰冻切片; 人类; 图 1b
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于免疫组化-冰冻切片在人类样本上 (图 1b). J Clin Invest (2019) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 s1a
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s1a). Eur J Immunol (2019) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 s1a
碧迪BD CD1D抗体（BD Biosciences, 562426)被用于被用于流式细胞仪在人类样本上 (图 s1a). J Clin Invest (2019) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD1D抗体（BD, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1a). Immunol Cell Biol (2019) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 3c
碧迪BD CD1D抗体（BD Biosciences, 557943)被用于被用于流式细胞仪在人类样本上 (图 3c). BMC Immunol (2019) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 4a). J Immunol (2019) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD1D抗体（BD, SK7)被用于被用于流式细胞仪在人类样本上 (图 1a). J Virol (2019) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 2d
碧迪BD CD1D抗体（BD Biosciences, SP-34-2)被用于被用于流式细胞仪在猕猴样本上 (图 2d). J Virol (2019) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 s5b, s5c
碧迪BD CD1D抗体（BD, 339186)被用于被用于流式细胞仪在人类样本上 (图 s5b, s5c). Cell (2018) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 图 5c, s5c
碧迪BD CD1D抗体（BD, 552852)被用于被用于流式细胞仪在人类样本上 (图 5c, s5c). Cell (2018) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 2a). Cancer (2019) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 2a
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在猕猴样本上 (图 2a). J Virol (2019) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 s1a
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s1a). Proc Natl Acad Sci U S A (2018) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 1a
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在猕猴样本上 (图 1a). J Virol (2019) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 s3
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 s3). J Infect Dis (2019) ncbi
小鼠 单克隆（SK7）
  • 免疫组化; 人类; 1:100; 图 3a
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于免疫组化在人类样本上浓度为1:100 (图 3a). Ann Allergy Asthma Immunol (2019) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1c
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1c). Int J Hematol (2018) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 s7c
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 s7c). Leukemia (2019) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 4d
碧迪BD CD1D抗体（BD Biosciences, 562426)被用于被用于流式细胞仪在人类样本上 (图 4d). Nat Immunol (2018) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD1D抗体（BD Bioscience, 557943)被用于被用于流式细胞仪在人类样本上 (图 2a). J Clin Invest (2018) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD1D抗体（BD Pharmingen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1a). Front Immunol (2018) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 s7b
碧迪BD CD1D抗体（BD, 555916)被用于被用于流式细胞仪在人类样本上 (图 s7b). Eur J Immunol (2018) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD1D抗体（BD Biosciences, 563423)被用于被用于流式细胞仪在人类样本上 (图 3a). Stem Cell Reports (2018) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 3
碧迪BD CD1D抗体（BD, 555333)被用于被用于流式细胞仪在人类样本上 (图 3). J Virol (2018) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 6h, 6i
碧迪BD CD1D抗体（BD, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 6h, 6i). Cancer Res (2018) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD1D抗体（BD Biosciences, 347344)被用于被用于流式细胞仪在人类样本上 (图 1a). Front Immunol (2018) ncbi
小鼠 单克隆（UCHT1）
  • 免疫组化-冰冻切片; 人类; 图 2a
  • 流式细胞仪; 人类; 图 1b
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于免疫组化-冰冻切片在人类样本上 (图 2a) 和 被用于流式细胞仪在人类样本上 (图 1b). J Exp Med (2018) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD1D抗体（BD Biosciences, 557851)被用于被用于流式细胞仪在人类样本上 (图 2a). J Virol (2018) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 1a
碧迪BD CD1D抗体（BD Biosciences, SP34.2)被用于被用于流式细胞仪在猕猴样本上 (图 1a). AIDS (2018) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; African green monkey; 图 s1a
碧迪BD CD1D抗体（BD Biosciences, 557757)被用于被用于流式细胞仪在African green monkey样本上 (图 s1a). J Clin Invest (2018) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 1
碧迪BD CD1D抗体（BD Biosciences, 555916)被用于被用于流式细胞仪在人类样本上 (图 1). Oncotarget (2018) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 14
碧迪BD CD1D抗体（BD Bioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 14). Front Immunol (2018) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 1a
碧迪BD CD1D抗体（BD Biosciences, 552127)被用于被用于流式细胞仪在猕猴样本上 (图 1a). Cell (2018) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 1e
碧迪BD CD1D抗体（BD, 555332)被用于被用于流式细胞仪在人类样本上 (图 1e). J Exp Med (2018) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1b
碧迪BD CD1D抗体（BD, 563219)被用于被用于流式细胞仪在人类样本上 (图 1b). J Exp Med (2018) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 3e
碧迪BD CD1D抗体（BD Biosciences, 561806)被用于被用于流式细胞仪在人类样本上 (图 3e). Cell (2018) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2018) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 4a). J Immunol (2018) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 5a
碧迪BD CD1D抗体（BD Pharmingen, SK7)被用于被用于流式细胞仪在人类样本上 (图 5a). Obes Facts (2017) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 2b
碧迪BD CD1D抗体（BD, SK7)被用于被用于流式细胞仪在人类样本上 (图 2b). Nat Med (2018) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 s2
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 s2). Nat Commun (2017) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD1D抗体（BD, SK7)被用于被用于流式细胞仪在人类样本上 (图 3a). J Virol (2018) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD1D抗体（BD Biosciences, UCHT - 1)被用于被用于流式细胞仪在人类样本上 (图 1a). Front Immunol (2017) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 s2
碧迪BD CD1D抗体（BD, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s2). Nat Commun (2017) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD1D抗体（BD, SK7)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2017) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 s4a
碧迪BD CD1D抗体（BD, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s4a). J Immunol (2017) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 s2e
碧迪BD CD1D抗体（BD, SK7)被用于被用于流式细胞仪在人类样本上 (图 s2e). Nature (2017) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. J Immunol (2017) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. Nature (2017) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 s8e
碧迪BD CD1D抗体（BD, SK7)被用于被用于流式细胞仪在人类样本上 (图 s8e). Nature (2017) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 1d
碧迪BD CD1D抗体（BD Pharmingen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1d). J Clin Invest (2017) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 s6d
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 s6d). Science (2017) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 5a
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 5a). Cancer Res (2017) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 图 5a
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在人类样本上 (图 5a). Cancer Res (2017) ncbi
小鼠 单克隆（SK7）
  • 免疫组化; 人类; 1:100; 图 1c
碧迪BD CD1D抗体（BD Biosciences, 349201)被用于被用于免疫组化在人类样本上浓度为1:100 (图 1c). J Immunol (2017) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 5c
碧迪BD CD1D抗体（BD, 562426)被用于被用于流式细胞仪在人类样本上 (图 5c). Blood (2017) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 6b
碧迪BD CD1D抗体（BD Biosciences, 561807)被用于被用于流式细胞仪在人类样本上 (图 6b). Mol Ther Methods Clin Dev (2017) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 表 2
碧迪BD CD1D抗体（BD, UCHT-1)被用于被用于流式细胞仪在人类样本上 (表 2). J Immunol Methods (2017) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2017) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 s2
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s2). Nature (2017) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; African green monkey; 图 s4
碧迪BD CD1D抗体（BD Biosciences, SP34.2)被用于被用于流式细胞仪在African green monkey样本上 (图 s4). Nature (2017) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. J Immunol (2017) ncbi
小鼠 单克隆（UCHT1）
  • 抑制或激活实验; 人类; 图 2e
碧迪BD CD1D抗体（BD, 555329)被用于被用于抑制或激活实验在人类样本上 (图 2e). Sci Rep (2017) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 表 s9
碧迪BD CD1D抗体（BD, 557757)被用于被用于流式细胞仪在人类样本上 (表 s9). Nature (2017) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 S1a
碧迪BD CD1D抗体（BD, 561807)被用于被用于流式细胞仪在人类样本上 (图 S1a). Sci Rep (2017) ncbi
小鼠 单克隆（HIT3a）
  • 流式细胞仪; 人类; 图 6
碧迪BD CD1D抗体（BD, 555340)被用于被用于流式细胞仪在人类样本上 (图 6). Sci Rep (2017) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1g
碧迪BD CD1D抗体（BD Biosciences, 347344)被用于被用于流式细胞仪在人类样本上 (图 1g). Oncoimmunology (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1). Clin Exp Immunol (2017) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 5
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 5). Genome Med (2017) ncbi
小鼠 单克隆（HIT3a）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, 555342)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2017) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（Pharmingen, SK7)被用于被用于流式细胞仪在人类样本上. Oncol Lett (2017) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. Clin Immunol (2017) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Bioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. Sci Rep (2017) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Bioscience, SK7)被用于被用于流式细胞仪在人类样本上. Sci Rep (2017) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 食蟹猴; 图 3a
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在食蟹猴样本上 (图 3a). J Immunol (2017) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 s1
碧迪BD CD1D抗体（BD Bioscience, SK7)被用于被用于流式细胞仪在人类样本上 (图 s1). Haematologica (2017) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 s1d
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在猕猴样本上 (图 s1d). PLoS Pathog (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在猕猴样本上. Vaccine (2017) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 表 3
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (表 3). Am J Pathol (2017) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 1a
碧迪BD CD1D抗体（Becton Dickinson, SP34-2)被用于被用于流式细胞仪在猕猴样本上 (图 1a). J Immunol (2017) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol Res (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 s1c
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 s1c). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 1:100; 图 s1c
碧迪BD CD1D抗体（BD, 349201)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 s1c). Nature (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 图 1d
碧迪BD CD1D抗体（BD Pharmigen, 552851)被用于被用于流式细胞仪在人类样本上 (图 1d). Nature (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 表 s2
碧迪BD CD1D抗体（BD Biosciences, 557757)被用于被用于流式细胞仪在人类样本上 (表 s2). Science (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 1:100; 图 2a
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 2a). J Leukoc Biol (2017) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 3e
碧迪BD CD1D抗体（BD Pharmingen, 557917)被用于被用于流式细胞仪在猕猴样本上 (图 3e). Transplantation (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD1D抗体（BD, 557917)被用于被用于流式细胞仪在人类样本上 (图 4a). Oncoimmunology (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 图 5d
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在人类样本上 (图 5d). J Immunol (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. J Virol (2017) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 1:20; 图 1c
碧迪BD CD1D抗体（BD Biosciences, 555332)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 1c). Nat Commun (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; African green monkey; 1:20; 图 4b
碧迪BD CD1D抗体（BD Biosciences, 552127)被用于被用于流式细胞仪在African green monkey样本上浓度为1:20 (图 4b). Nat Commun (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 s11a
碧迪BD CD1D抗体（BD Pharmingen, 557917)被用于被用于流式细胞仪在猕猴样本上 (图 s11a). Science (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 5b
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 5b). JCI Insight (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 6
碧迪BD CD1D抗体（BD Biosciences, UCHTI)被用于被用于流式细胞仪在人类样本上 (图 6). New Microbiol (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 6a
碧迪BD CD1D抗体（BD, 557757)被用于被用于流式细胞仪在猕猴样本上 (图 6a). PLoS Pathog (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1a, 1e
碧迪BD CD1D抗体（BD Biosciences, 557851)被用于被用于流式细胞仪在人类样本上 (图 1a, 1e). JCI Insight (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD1D抗体（BD Biosciences, 557943)被用于被用于流式细胞仪在人类样本上 (图 2a). Cell (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, 560835)被用于被用于流式细胞仪在人类样本上. Oncotarget (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD, UCHT1)被用于被用于流式细胞仪在人类样本上. J Exp Med (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 5a
碧迪BD CD1D抗体（BD, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 5a). J Exp Med (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 s7
碧迪BD CD1D抗体（BD Biosciences, 563546)被用于被用于流式细胞仪在人类样本上 (图 s7). Cell (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD1D抗体（BD, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1a). Clin Immunol (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 3c
碧迪BD CD1D抗体（BD Biosciences, 557832)被用于被用于流式细胞仪在人类样本上 (图 3c). Nanomedicine (Lond) (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 7
碧迪BD CD1D抗体（BD Horizon, 563798)被用于被用于流式细胞仪在人类样本上 (图 7). Oncoimmunology (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1
碧迪BD CD1D抗体（BD Bioscience, SK7)被用于被用于流式细胞仪在人类样本上 (图 1). J Interferon Cytokine Res (2016) ncbi
小鼠 单克隆（SK7）
  • 免疫组化; 人类; 图 2a
碧迪BD CD1D抗体（Becton Dickinson, SK7)被用于被用于免疫组化在人类样本上 (图 2a). Rheumatology (Oxford) (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 s1a
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 s1a). Sci Rep (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 st9
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 st9). JCI Insight (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1
碧迪BD CD1D抗体（BD Biosciences, 349201)被用于被用于流式细胞仪在人类样本上 (图 1). Mol Med Rep (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 s1a
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s1a). J Immunol (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 1a
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在猕猴样本上 (图 1a). J Virol (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 s2b
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 s2b). Oncotarget (2016) ncbi
小鼠 单克隆（CD1d42）
  • 流式细胞仪; 人类; 图 s1
碧迪BD CD1D抗体（BD Biosciences, 550255)被用于被用于流式细胞仪在人类样本上 (图 s1). MBio (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. Biomaterials (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 9
碧迪BD CD1D抗体（BD Pharmingen, 557694)被用于被用于流式细胞仪在人类样本上 (图 9). Sci Rep (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 2e
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 2e). J Immunol (2016) ncbi
小鼠 单克隆（CD1d42）
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD1D抗体（BD Biosciences, CD1d42)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1a). Cytometry B Clin Cytom (2018) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1e
碧迪BD CD1D抗体（BD, SK7)被用于被用于流式细胞仪在人类样本上 (图 1e). J Allergy Clin Immunol (2017) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD1D抗体（BD, SK7)被用于被用于流式细胞仪在人类样本上 (图 4a). J Immunol (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 4b
碧迪BD CD1D抗体（Biosciences, SP34-2)被用于被用于流式细胞仪在猕猴样本上 (图 4b). J Immunol (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 3
碧迪BD CD1D抗体（BD, 557943)被用于被用于流式细胞仪在人类样本上 (图 3). PLoS Pathog (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1d
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1d). Clin Transl Gastroenterol (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 图 s3c
碧迪BD CD1D抗体（BD Bioscience, SP34-2)被用于被用于流式细胞仪在人类样本上 (图 s3c). Science (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 表 1
碧迪BD CD1D抗体（BD, SP34-2)被用于被用于流式细胞仪在猕猴样本上 (表 1). Am J Pathol (2016) ncbi
小鼠 单克隆（SP34）
  • 流式细胞仪; 猕猴; 表 1
碧迪BD CD1D抗体（BD, SP34-2)被用于被用于流式细胞仪在猕猴样本上 (表 1). Am J Pathol (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 s2
碧迪BD CD1D抗体（BD Bioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s2). J Clin Invest (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 s3a
碧迪BD CD1D抗体（BD, SK7)被用于被用于流式细胞仪在人类样本上 (图 s3a). J Clin Invest (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 图 6
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在人类样本上 (图 6). J Transl Med (2016) ncbi
小鼠 单克隆（SP34）
  • 流式细胞仪; 人类; 图 6
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在人类样本上 (图 6). J Transl Med (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 3b
  • 流式细胞仪; 小鼠; 图 st1
碧迪BD CD1D抗体（BD Pharmingen, SK7)被用于被用于流式细胞仪在人类样本上 (图 3b) 和 被用于流式细胞仪在小鼠样本上 (图 st1). J Clin Invest (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD1D抗体（Biosciences, 340949)被用于被用于流式细胞仪在人类样本上 (图 2a). Mol Imaging Biol (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 s3
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s3). Sci Rep (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 1:80
碧迪BD CD1D抗体（BD Biosciences, 557917)被用于被用于流式细胞仪在猕猴样本上浓度为1:80. Nat Med (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 5e
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 5e). J Immunol (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 s5b
碧迪BD CD1D抗体（BD Bioscience, SK7)被用于被用于流式细胞仪在人类样本上 (图 s5b). Nat Commun (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 1:50; 图 1d
碧迪BD CD1D抗体（BD, SK7)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 1d). Nat Med (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 3d
碧迪BD CD1D抗体（BD Pharmingen, SK7)被用于被用于流式细胞仪在人类样本上 (图 3d). J Leukoc Biol (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 1:50; 图 1e
碧迪BD CD1D抗体（BD, 557851)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 1e). Nat Cell Biol (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 1:100; 图 1
碧迪BD CD1D抗体（Becton Dickinson, SK7)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 1). PLoS ONE (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 1:50; 图 2
碧迪BD CD1D抗体（BD PharMingen, 347347)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 2). Oncoimmunology (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 1:40; 图 3
碧迪BD CD1D抗体（BD PharMingen, 560365)被用于被用于流式细胞仪在人类样本上浓度为1:40 (图 3). Oncoimmunology (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD1D抗体（BD Biosciences, 560835)被用于被用于流式细胞仪在人类样本上 (图 2a). J Immunother Cancer (2016) ncbi
小鼠 单克隆（HIT3a）
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD1D抗体（BD Biosciences, 555342)被用于被用于流式细胞仪在人类样本上 (图 2a). J Immunother Cancer (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 s1a
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s1a). Eur J Immunol (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴
碧迪BD CD1D抗体（BD Biosciences, SP34.2)被用于被用于流式细胞仪在猕猴样本上. PLoS ONE (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 4
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 4). Ann Clin Transl Neurol (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 1g
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在猕猴样本上 (图 1g). J Immunol (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1a). J Crohns Colitis (2016) ncbi
小鼠 单克隆（CD1d42）
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD1D抗体（BD, 550255)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆（HIT3a）
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD1D抗体（BD, 555340)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD, 562280)被用于被用于流式细胞仪在人类样本上. Oncoimmunology (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1). J Crohns Colitis (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 表 2
碧迪BD CD1D抗体（BD Bioscience, 641397)被用于被用于流式细胞仪在人类样本上 (表 2). Sci Rep (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; African green monkey; 图 4a
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在African green monkey样本上 (图 4a). Infect Immun (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Bioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. J Immunol (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 s1
碧迪BD CD1D抗体（BD Biosciences Pharmingen, SP34)被用于被用于流式细胞仪在猕猴样本上 (图 s1). Mucosal Immunol (2016) ncbi
小鼠 单克隆（SP34）
  • 流式细胞仪; 猕猴; 图 s1
碧迪BD CD1D抗体（BD Biosciences Pharmingen, SP34)被用于被用于流式细胞仪在猕猴样本上 (图 s1). Mucosal Immunol (2016) ncbi
小鼠 单克隆（UCHT1）
  • 抑制或激活实验; 人类; 1 ug/ml
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml. J Immunol (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 图 1c
碧迪BD CD1D抗体（BD, SP34-2)被用于被用于流式细胞仪在人类样本上 (图 1c). PLoS Pathog (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD1D抗体（BD Pharmingen, SK7)被用于被用于流式细胞仪在人类样本上 (图 2a). PLoS ONE (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 2b
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 2b). J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆（SP34）
  • 流式细胞仪; African green monkey; 图 1
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在African green monkey样本上 (图 1). J Immunol (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; African green monkey; 图 1
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在African green monkey样本上 (图 1). J Immunol (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 7.45.3
碧迪BD CD1D抗体（BD Biosciences, 641406)被用于被用于流式细胞仪在人类样本上 (图 7.45.3). Curr Protoc Cytom (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1a). PLoS ONE (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1b
碧迪BD CD1D抗体（BD, SK7)被用于被用于流式细胞仪在人类样本上 (图 1b). J Virol (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 7
碧迪BD CD1D抗体（BD PharMingen, 563423)被用于被用于流式细胞仪在人类样本上 (图 7). MAbs (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD1D抗体（BD Biosciences, 349201)被用于被用于流式细胞仪在人类样本上 (图 3a). Mol Med Rep (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. J Biol Chem (2016) ncbi
小鼠 单克隆（SP34）
  • 流式细胞仪; 猕猴; 图 4
碧迪BD CD1D抗体（BD Biosciences, SP34.2)被用于被用于流式细胞仪在猕猴样本上 (图 4). J Virol (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 4
碧迪BD CD1D抗体（BD Biosciences, SP34.2)被用于被用于流式细胞仪在猕猴样本上 (图 4). J Virol (2016) ncbi
小鼠 单克隆（CD1d42）
  • 流式细胞仪; 人类; 1:10; 图 3
碧迪BD CD1D抗体（BD, 550255)被用于被用于流式细胞仪在人类样本上浓度为1:10 (图 3). PLoS ONE (2015) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 5
碧迪BD CD1D抗体（BD Biosciences, SP34.2)被用于被用于流式细胞仪在猕猴样本上 (图 5). Clin Exp Immunol (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 1
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD1D抗体（BD Pharmingen, SP34-2)被用于被用于流式细胞仪在人类样本上 (图 2a). Eur J Immunol (2016) ncbi
小鼠 单克隆（UCHT1）
  • 抑制或激活实验; 小鼠; 图 1c
碧迪BD CD1D抗体（BD Biosciences, 555329)被用于被用于抑制或激活实验在小鼠样本上 (图 1c). Nat Commun (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 4
碧迪BD CD1D抗体（BD Biosciences, 563423)被用于被用于流式细胞仪在人类样本上 (图 4). MAbs (2016) ncbi
小鼠 单克隆（CD1d42）
  • 流式细胞仪; 人类; 图 s3
碧迪BD CD1D抗体（BD Biosciences, CD1d42)被用于被用于流式细胞仪在人类样本上 (图 s3). Sci Transl Med (2015) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 2
碧迪BD CD1D抗体（BD, 557757)被用于被用于流式细胞仪在猕猴样本上 (图 2). Nat Commun (2015) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD, SP34-2)被用于被用于流式细胞仪在人类样本上. Am J Transplant (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 2
碧迪BD CD1D抗体（BD Biosciences, 560275)被用于被用于流式细胞仪在人类样本上 (图 2). Retrovirology (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 1
碧迪BD CD1D抗体（BD Biosciences, # 557943)被用于被用于流式细胞仪在人类样本上 (图 1). Immunol Res (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD PharMingen, 347344)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD1D抗体（BD PharMingen, SK7)被用于被用于流式细胞仪在人类样本上 (图 3a). Hum Vaccin Immunother (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 1
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS Pathog (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD, 555332)被用于被用于流式细胞仪在人类样本上. Cytotherapy (2015) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 2a
碧迪BD CD1D抗体（BD Biosciences, SP34.2)被用于被用于流式细胞仪在猕猴样本上 (图 2a). J Infect Dis (2016) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. J Immunol (2015) ncbi
小鼠 单克隆（SP34）
  • 流式细胞仪; 小鼠; 图 4
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在小鼠样本上 (图 4). J Virol (2015) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 小鼠; 图 4
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在小鼠样本上 (图 4). J Virol (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Bioscience, 347344)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 表 1
碧迪BD CD1D抗体（BD, SK7)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry B Clin Cytom (2016) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 1:20
碧迪BD CD1D抗体（BD Biosciences, 552851)被用于被用于流式细胞仪在人类样本上浓度为1:20. Nat Commun (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（Becton Dickinson, UCHT1)被用于被用于流式细胞仪在人类样本上. Biol Blood Marrow Transplant (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 4
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 4). PLoS ONE (2015) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 图 3
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在人类样本上 (图 3). Mucosal Immunol (2016) ncbi
小鼠 单克隆（SK7）
  • 免疫组化; 人类; 表 s4
碧迪BD CD1D抗体（BD Biosciences, 347340)被用于被用于免疫组化在人类样本上 (表 s4). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 1
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在猕猴样本上 (图 1). J Virol (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 猕猴
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在猕猴样本上. Vaccine (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1
碧迪BD CD1D抗体（BD Bioscience, 557832)被用于被用于流式细胞仪在人类样本上 (图 1). J Hematol Oncol (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 2a). Ann Rheum Dis (2016) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD, 560366)被用于被用于流式细胞仪在人类样本上. J Exp Med (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 4
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 4). J Immunol (2015) ncbi
小鼠 单克隆（UCHT1）
  • 抑制或激活实验; 人类
碧迪BD CD1D抗体（BD Pharmingen, 555329)被用于被用于抑制或激活实验在人类样本上. J Immunol Methods (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 3
碧迪BD CD1D抗体（BD Biosciences, 555333)被用于被用于流式细胞仪在人类样本上 (图 3). Stem Cell Rev (2015) ncbi
小鼠 单克隆（SP34-2）
碧迪BD CD1D抗体（BD bioscience, 561805)被用于. J Immunol (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 2
碧迪BD CD1D抗体（BD Bioscience, SK7)被用于被用于流式细胞仪在人类样本上 (图 2). Nat Immunol (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD PharMingen, 561027)被用于被用于流式细胞仪在人类样本上. MAbs (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 S1
碧迪BD CD1D抗体（BD Pharmingen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 S1). Retrovirology (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 1:400; 图 1
碧迪BD CD1D抗体（BD, 562426)被用于被用于流式细胞仪在人类样本上浓度为1:400 (图 1). Clin Vaccine Immunol (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 6
碧迪BD CD1D抗体（Becton Dickinson, SK7)被用于被用于流式细胞仪在人类样本上 (图 6). Bone Marrow Transplant (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 表 4
碧迪BD CD1D抗体（BD Bioscience, SK7)被用于被用于流式细胞仪在人类样本上 (表 4). Cytometry B Clin Cytom (2015) ncbi
小鼠 单克隆（SP34）
  • 流式细胞仪; African green monkey
碧迪BD CD1D抗体（BD Biosciences, SP34-1)被用于被用于流式细胞仪在African green monkey样本上. J Infect Dis (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. J Immunol (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 表 1
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (表 1). Cancer Immunol Immunother (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 2:100; 图 3a
碧迪BD CD1D抗体（Becton Dickinson, SK7)被用于被用于流式细胞仪在人类样本上浓度为2:100 (图 3a). Nat Commun (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 1e
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1e). J Immunol (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD, SK7)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 5 ul/test
碧迪BD CD1D抗体（BD Pharmingen, SK7)被用于被用于流式细胞仪在人类样本上浓度为5 ul/test. J Immunol Methods (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 食蟹猴
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD, 340440)被用于被用于流式细胞仪在食蟹猴样本上 和 被用于流式细胞仪在人类样本上. MAbs (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. PLoS Med (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1
碧迪BD CD1D抗体（BD Pharmingen, SK7)被用于被用于流式细胞仪在人类样本上 (图 1). J Infect Dis (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 表 2
碧迪BD CD1D抗体（BD Bioscience, SK7)被用于被用于流式细胞仪在人类样本上 (表 2). Clin Transplant (2015) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; African green monkey; 图 4a
碧迪BD CD1D抗体（BD Pharmingen, SP34-2)被用于被用于流式细胞仪在African green monkey样本上 (图 4a). PLoS Pathog (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 2
碧迪BD CD1D抗体（BD Pharmingen, SK7)被用于被用于流式细胞仪在人类样本上 (图 2). J Virol (2015) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Pharmingen, SP34-2)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2015) ncbi
小鼠 单克隆（SK7）
  • 抑制或激活实验; 人类; 图 s3
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于抑制或激活实验在人类样本上 (图 s3). Diabetes (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Pharmingen, 562426)被用于被用于流式细胞仪在人类样本上. Alcohol (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（Becton Dickinson, UCHT1)被用于被用于流式细胞仪在人类样本上. J Leukoc Biol (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 0.5:100
碧迪BD CD1D抗体（BD, 561007)被用于被用于流式细胞仪在人类样本上浓度为0.5:100. Cytometry A (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Bioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. Immun Inflamm Dis (2014) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在人类样本上. Immun Inflamm Dis (2014) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在猕猴样本上. PLoS Pathog (2014) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. J Immunol Methods (2015) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴
碧迪BD CD1D抗体（BD Biosciences, SP34.2)被用于被用于流式细胞仪在猕猴样本上. J Infect Dis (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD, UCHT1)被用于被用于流式细胞仪在人类样本上. Eur J Cancer (2015) ncbi
小鼠 单克隆（CD1d42）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD, CD1d42)被用于被用于流式细胞仪在人类样本上. Eur J Cancer (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. Eur J Immunol (2015) ncbi
小鼠 单克隆（HIT3a）
  • 流式细胞仪; 人类; 图 2
碧迪BD CD1D抗体（BD Biosciences, 555342)被用于被用于流式细胞仪在人类样本上 (图 2). Clin Cancer Res (2015) ncbi
小鼠 单克隆（SP34）
  • 流式细胞仪; 食蟹猴; 图 s2
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在食蟹猴样本上 (图 s2). J Autoimmun (2015) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 食蟹猴; 图 s2
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在食蟹猴样本上 (图 s2). J Autoimmun (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, 557694)被用于被用于流式细胞仪在人类样本上. Cancer Res (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD, SK7)被用于被用于流式细胞仪在人类样本上. Cytometry B Clin Cytom (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Pharmingen, clone SK7)被用于被用于流式细胞仪在人类样本上. Chest (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Pharmingen, UCHT1)被用于被用于流式细胞仪在人类样本上. Chest (2015) ncbi
小鼠 单克隆（UCHT1）
  • 抑制或激活实验; 人类; 1 ug/ml
碧迪BD CD1D抗体（BD, UCHT1)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml. Nat Immunol (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 1:50
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上浓度为1:50. Nat Commun (2014) ncbi
小鼠 单克隆（UCHT1）
  • 抑制或激活实验; 人类; 1 ug/ml; 图 2
碧迪BD CD1D抗体（BD Pharmingen, 555329)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml (图 2). Mol Cell Biol (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在猕猴样本上. J Immunol (2014) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在猕猴样本上. J Leukoc Biol (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2014) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 图 5
碧迪BD CD1D抗体（BD, SP34-2)被用于被用于流式细胞仪在人类样本上 (图 5). Clin Cancer Res (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. J Virol (2015) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 小鼠; 图 s3
碧迪BD CD1D抗体（Pharmingen, 555332)被用于被用于流式细胞仪在小鼠样本上 (图 s3). Stem Cell Res (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Pharmingen, UCHT1)被用于被用于流式细胞仪在人类样本上. J Hepatol (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. Cytotherapy (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
  • 免疫细胞化学; 人类
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 和 被用于免疫细胞化学在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴
碧迪BD CD1D抗体（BD Biosciences, SP-34-2)被用于被用于流式细胞仪在猕猴样本上. J Immunol (2014) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; baboons; 图 1
碧迪BD CD1D抗体（Becton-Dickinson, clone SP34-2)被用于被用于流式细胞仪在baboons样本上 (图 1). PLoS ONE (2014) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. Cytometry B Clin Cytom (2014) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD, SK7)被用于被用于流式细胞仪在人类样本上. Eur J Immunol (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD, UCHT1)被用于被用于流式细胞仪在人类样本上. Eur J Immunol (2014) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类; 图 2
碧迪BD CD1D抗体（BD Pharmingen, clone SP34-2)被用于被用于流式细胞仪在人类样本上 (图 2). Clin Immunol (2014) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD, SK7)被用于被用于流式细胞仪在人类样本上. J Exp Med (2014) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD, SK7)被用于被用于流式细胞仪在人类样本上. J Exp Med (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Pharmingen, UCHT1)被用于被用于流式细胞仪在人类样本上. Inflamm Bowel Dis (2014) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, Clone SK7)被用于被用于流式细胞仪在人类样本上. Vaccine (2014) ncbi
小鼠 单克隆（UCHT1）
  • 免疫细胞化学; 小鼠
碧迪BD CD1D抗体（PharMingen, UCHT1)被用于被用于免疫细胞化学在小鼠样本上. Hum Pathol (2014) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, 552127)被用于被用于流式细胞仪在人类样本上. Xenotransplantation (2015) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. Proc Natl Acad Sci U S A (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD, UCHT1)被用于被用于流式细胞仪在人类样本上. Front Immunol (2014) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴
碧迪BD CD1D抗体（BD Pharmingen, 557917)被用于被用于流式细胞仪在猕猴样本上. J Virol (2014) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在猕猴样本上. Antimicrob Agents Chemother (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD PharMingen, UCHT1)被用于被用于流式细胞仪在人类样本上. J Leukoc Biol (2014) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1). J Infect Dis (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. Immunobiology (2015) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Horizon, UCHT1)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 s1
碧迪BD CD1D抗体（BD Bioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s1). J Immunol (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. Blood (2014) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Bioscience, SK7)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆（SP34）
  • 流式细胞仪; African green monkey; 图 s1
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在African green monkey样本上 (图 s1). PLoS Pathog (2014) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; African green monkey; 图 s1
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在African green monkey样本上 (图 s1). PLoS Pathog (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 1:20
碧迪BD CD1D抗体（BD Biosciences, 560365)被用于被用于流式细胞仪在人类样本上浓度为1:20. J Immunol (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD, UCHT1)被用于被用于流式细胞仪在人类样本上. J Exp Med (2014) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 1:40
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上浓度为1:40. Nat Commun (2014) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴; 图 s1a
碧迪BD CD1D抗体（BD Pharmingen, SP34-2)被用于被用于流式细胞仪在猕猴样本上 (图 s1a). J Immunol (2014) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. J Virol (2014) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; African green monkey
碧迪BD CD1D抗体（BD Pharmingen, SP34-2)被用于被用于流式细胞仪在African green monkey样本上. Int Immunol (2014) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴
碧迪BD CD1D抗体（BD Bioscience, SP34-2)被用于被用于流式细胞仪在猕猴样本上. Clin Immunol (2014) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 小鼠
碧迪BD CD1D抗体（BD Pharmingen, SP34-2)被用于被用于流式细胞仪在小鼠样本上. FASEB J (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. J Clin Immunol (2014) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆（SP34）
  • 流式细胞仪; African green monkey; 表 1
碧迪BD CD1D抗体（BD, SP34)被用于被用于流式细胞仪在African green monkey样本上 (表 1). Am J Transplant (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（Becton Dickinson, UCHT1)被用于被用于流式细胞仪在人类样本上. Biomed Res Int (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 1.6:100
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上浓度为1.6:100. J Clin Invest (2014) ncbi
小鼠 单克隆（SP34）
  • 流式细胞仪; 黑猩猩
碧迪BD CD1D抗体（BD Biosciences, SP34.2)被用于被用于流式细胞仪在黑猩猩样本上. J Med Primatol (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. Int J Cancer (2014) ncbi
小鼠 单克隆（SK7）
  • 免疫组化; 人类
碧迪BD CD1D抗体（Becton Dickinson, SK7)被用于被用于免疫组化在人类样本上. Arthritis Rheumatol (2014) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; African green monkey; 图 1a
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在African green monkey样本上 (图 1a). Cell Immunol (2014) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, clone SP34-2)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 大鼠
碧迪BD CD1D抗体（BD, 557832)被用于被用于流式细胞仪在大鼠样本上. J Immunol (2014) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 猕猴
碧迪BD CD1D抗体（BD, SP34-2)被用于被用于流式细胞仪在猕猴样本上. PLoS ONE (2014) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SP34-2)被用于被用于流式细胞仪在人类样本上. Cytometry A (2014) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 表 1
碧迪BD CD1D抗体（BD Bio-sciences, clone SK7)被用于被用于流式细胞仪在人类样本上 (表 1). Environ Toxicol Pharmacol (2014) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD1D抗体（Becton Dickinson, SK7)被用于被用于流式细胞仪在人类样本上 (图 1a). Clin Immunol (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD, 555332)被用于被用于流式细胞仪在人类样本上. Nat Med (2014) ncbi
小鼠 单克隆（SP34-2）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD/Pharmingen, SP34-2)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD/Pharmingen, UCHT1)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2014) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, SK7)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2014) ncbi
小鼠 单克隆（CD1d42）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD, 550255)被用于被用于流式细胞仪在人类样本上. Mol Cells (2013) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Bioscience, SK7)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Bioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2014) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 表 1
碧迪BD CD1D抗体（BD, clone SK7)被用于被用于流式细胞仪在人类样本上 (表 1). Cytopathology (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD Biosciences, UCHT1)被用于被用于流式细胞仪在人类样本上. Retrovirology (2013) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类
碧迪BD CD1D抗体（BD, UCHT1)被用于被用于流式细胞仪在人类样本上. Ann Rheum Dis (2014) ncbi
小鼠 单克隆（SK7）
  • 流式细胞仪; 人类; 图 1
碧迪BD CD1D抗体（BD, 641406)被用于被用于流式细胞仪在人类样本上 (图 1). Cytometry B Clin Cytom (2014) ncbi
小鼠 单克隆（UCHT1）
  • 流式细胞仪; 人类; 图 5
碧迪BD CD1D抗体（BD Pharmingen, 555332)被用于被用于流式细胞仪在人类样本上 (图 5). Cell Transplant (2014) ncbi
小鼠 单克隆（UCHT1）
  • 免疫组化-冰冻切片; 人类; 0.25 ug/ml
碧迪BD CD1D抗体（BD Pharmingen, 555330)被用于被用于免疫组化-冰冻切片在人类样本上浓度为0.25 ug/ml. Neuropathol Appl Neurobiol (2014) ncbi
小鼠 单克隆（SK7）
  • 免疫组化; 人类
碧迪BD CD1D抗体（BD, SK7)被用于被用于免疫组化在人类样本上. Blood (2008) ncbi
小鼠 单克隆（SP34）
  • 流式细胞仪; South American squirrel monkey
碧迪BD CD1D抗体（BD, SP34)被用于被用于流式细胞仪在South American squirrel monkey样本上. J Immunol Methods (2005) ncbi
徕卡显微系统(上海)贸易有限公司
单克隆（LN10）
  • 免疫组化-石蜡切片; 小鼠; 1:500; 图 4b
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Novocastra, LN10)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:500 (图 4b). J Cell Sci (2022) ncbi
单克隆（LN10）
  • 免疫组化-石蜡切片; 人类; 图 6d
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Leica, PA0554)被用于被用于免疫组化-石蜡切片在人类样本上 (图 6d). Mol Cancer (2021) ncbi
  • 免疫组化-石蜡切片; 人类; 1:200
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Leica, NCL-L-CD3-565)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200. Front Oncol (2021) ncbi
单克隆（LN10）
  • 免疫组化-石蜡切片; 人类; 1:50; 图 s5e
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Leica, LN10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (图 s5e). Acta Neuropathol (2021) ncbi
单克隆（LN10）
  • 流式细胞仪; pigs ; 图 2
  • 免疫组化; pigs ; 图 3
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Leica Biosystems, LN10)被用于被用于流式细胞仪在pigs 样本上 (图 2) 和 被用于免疫组化在pigs 样本上 (图 3). Front Immunol (2020) ncbi
单克隆（LN10）
  • 免疫组化-石蜡切片; 人类; 1:200; 图 2
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Leica, LN10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 2). Cancer Sci (2020) ncbi
  • 免疫组化-石蜡切片; 人类; 1:50; 图 5a
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Leica, NCL-L-CD3-565)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (图 5a). Acta Neuropathol Commun (2019) ncbi
单克隆（LN10）
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 6i
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Leica/Novocastra, LN10)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 6i). Acta Neuropathol Commun (2019) ncbi
  • 免疫组化-石蜡切片; 人类; 1:100; 图 1d
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Leica, NCL-L-CD3-565)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 1d). Nat Med (2019) ncbi
  • 免疫组化; 人类; 1:200; 图 1c
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Leica, NCL-L-CD3-565)被用于被用于免疫组化在人类样本上浓度为1:200 (图 1c). JCO Precis Oncol (2019) ncbi
  • 免疫组化; 人类; 图 6f
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Leica, NCL-L-CD3-565)被用于被用于免疫组化在人类样本上 (图 6f). Cell (2019) ncbi
单克隆（LN10）
  • 免疫组化-石蜡切片; 人类; 图 s18i
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Leica, LN10)被用于被用于免疫组化-石蜡切片在人类样本上 (图 s18i). Science (2018) ncbi
单克隆（LN10）
  • 免疫组化-石蜡切片; 人类; 图 4
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Leica, PA0554)被用于被用于免疫组化-石蜡切片在人类样本上 (图 4). J Proteome Res (2017) ncbi
  • 免疫组化-石蜡切片; 人类; 1:50; 图 5b
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Leica Biosystems, NCL-L-CD3-565)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (图 5b). J Cutan Pathol (2017) ncbi
单克隆（LN10）
  • 免疫组化-石蜡切片; 人类; 图 1a
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Novocastra, LN10)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1a). Histopathology (2017) ncbi
单克隆（LN10）
  • 免疫组化-石蜡切片; 人类; 1:500; 表 1
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Novocastra, LN10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:500 (表 1). Rom J Morphol Embryol (2016) ncbi
单克隆（LN10）
  • 免疫组化-石蜡切片; 人类; 1:100; 图 5
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Leica, PA0554)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 5). Oncoimmunology (2016) ncbi
  • 免疫组化-石蜡切片; 人类; 图 2
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Novocastra, NCL-CD3-PS1)被用于被用于免疫组化-石蜡切片在人类样本上 (图 2). Clin Cancer Res (2016) ncbi
单克隆
  • 免疫组化-石蜡切片; 人类; 1:60; 图 2c
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Novocastra, CD3-PS1)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:60 (图 2c). Mod Pathol (2015) ncbi
  • 免疫组化-石蜡切片; 人类; 1:60; 图 2c
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Novocastra, CD3-PS1)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:60 (图 2c). Mod Pathol (2015) ncbi
单克隆（LN10）
  • 免疫组化-石蜡切片; 人类; 1:200; 图 3
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Novocastra, LN10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 3). Am J Surg Pathol (2015) ncbi
单克隆（LN10）
  • 免疫组化-石蜡切片; 人类; 1:1
徕卡显微系统(上海)贸易有限公司 CD1D抗体（Leica, LN10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:1. Cytopathology (2016) ncbi
文章列表
  1. Ravindranathan S, Passang T, Li J, Wang S, Dhamsania R, Ware M, et al. Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma. Nat Commun. 2022;13:6418 pubmed 出版商
  2. Kaminski M, Bendzick L, Hopps R, Kauffman M, Kodal B, Soignier Y, et al. TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity. J Immunother Cancer. 2022;10: pubmed 出版商
  3. Sullivan P, Kumar R, Li W, Hoglund V, Wang L, Zhang Y, et al. FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma. Mol Cancer Ther. 2022;21:1608-1621 pubmed 出版商
  4. Yong L, Yu Y, Li B, Ge H, Zhen Q, Mao Y, et al. Calcium/calmodulin-dependent protein kinase IV promotes imiquimod-induced psoriatic inflammation via macrophages and keratinocytes in mice. Nat Commun. 2022;13:4255 pubmed 出版商
  5. Jin Y, Lorvik K, Jin Y, Beck C, Sike A, Persiconi I, et al. Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer. Mol Ther Oncolytics. 2022;26:189-206 pubmed 出版商
  6. Omari S, Geraghty D, Khalafallah A, Venkat P, Shegog Y, Ragg S, et al. Optimized flow cytometric detection of transient receptor potential vanilloid-1 (TRPV1) in human hematological malignancies. Med Oncol. 2022;39:81 pubmed 出版商
  7. Liu H, Liu Y, Zhao Z, Li Y, Mustafa B, Chen Z, et al. Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy. Front Immunol. 2022;13:838966 pubmed 出版商
  8. Pantasis S, Friemel J, Brütsch S, Hu Z, Krautbauer S, Liebisch G, et al. Vertebrate lonesome kinase modulates the hepatocyte secretome to prevent perivascular liver fibrosis and inflammation. J Cell Sci. 2022;135: pubmed 出版商
  9. Boby N, Cao X, Williams K, Gadila S, Shroyer M, Didier P, et al. Simian Immunodeficiency Virus Infection Mediated Changes in Jejunum and Peripheral SARS-CoV-2 Receptor ACE2 and Associated Proteins or Genes in Rhesus Macaques. Front Immunol. 2022;13:835686 pubmed 出版商
  10. Araujo A, Abaurrea A, Azcoaga P, L xf3 pez Velazco J, Manzano S, Rodriguez J, et al. Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment. J Clin Invest. 2022;132: pubmed 出版商
  11. Besnard M, S xe9 razin C, Ossart J, Moreau A, Vimond N, Flippe L, et al. Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. J Clin Invest. 2022;132: pubmed 出版商
  12. Pinkert J, Boehm H, Trautwein M, Doecke W, Wessel F, Ge Y, et al. T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interaction. Oncoimmunology. 2022;11:2008110 pubmed 出版商
  13. Kushnareva E, Kushnarev V, Artemyeva A, Mitrofanova L, Moiseeva O. Myocardial PD-L1 Expression in Patients With Ischemic and Non-ischemic Heart Failure. Front Cardiovasc Med. 2021;8:759972 pubmed 出版商
  14. Chen Y, Feng R, He B, Wang J, Xian N, Huang G, et al. PD-1H Expression Associated With CD68 Macrophage Marker Confers an Immune-Activated Microenvironment and Favorable Overall Survival in Human Esophageal Squamous Cell Carcinoma. Front Mol Biosci. 2021;8:777370 pubmed 出版商
  15. Hülskötter K, Luhder F, Flügel A, Herder V, Baumgartner W. Tamoxifen Application Is Associated with Transiently Increased Loss of Hippocampal Neurons following Virus Infection. Int J Mol Sci. 2021;22: pubmed 出版商
  16. Moreira T, Mangani D, Cox L, Leibowitz J, Lobo E, Oliveira M, et al. PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasis. Nat Commun. 2021;12:4907 pubmed 出版商
  17. Petersen B, Kammerer R, Frenzel A, Hassel P, Dau T, Becker R, et al. Generation and first characterization of TRDC-knockout pigs lacking γδ T cells. Sci Rep. 2021;11:14965 pubmed 出版商
  18. Dalla Pietà A, Cappuzzello E, Palmerini P, Ventura A, Visentin A, Astori G, et al. Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. J Immunother Cancer. 2021;9: pubmed 出版商
  19. Li D, Edwards R, Manne K, Martinez D, Schäfer A, Alam S, et al. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell. 2021;184:4203-4219.e32 pubmed 出版商
  20. Marquez Exposito L, Tejedor Santamaria L, Santos Sánchez L, Valentijn F, Cantero Navarro E, Rayego Mateos S, et al. Acute Kidney Injury is Aggravated in Aged Mice by the Exacerbation of Proinflammatory Processes. Front Pharmacol. 2021;12:662020 pubmed 出版商
  21. Altvater B, Kailayangiri S, Pérez Lanuza L, Urban K, Greune L, Flügge M, et al. HLA-G and HLA-E Immune Checkpoints Are Widely Expressed in Ewing Sarcoma but Have Limited Functional Impact on the Effector Functions of Antigen-Specific CAR T Cells. Cancers (Basel). 2021;13: pubmed 出版商
  22. Li N, Torres M, Spetz M, Wang R, Peng L, Tian M, et al. CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice. Cell Rep Med. 2021;2:100297 pubmed 出版商
  23. Bohannon C, Ende Z, Cao W, Mboko W, Ranjan P, Kumar A, et al. Influenza Virus Infects and Depletes Activated Adaptive Immune Responders. Adv Sci (Weinh). 2021;8:e2100693 pubmed 出版商
  24. Yan C, Saleh N, Yang J, Nebhan C, Vilgelm A, Reddy E, et al. Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade. Mol Cancer. 2021;20:85 pubmed 出版商
  25. Kemp S, Carpenter E, Steele N, Donahue K, Nwosu Z, Pacheco A, et al. Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB-Mediated Production of CXCL1. Cancer Res. 2021;81:4305-4318 pubmed 出版商
  26. Williams W, Meyerhoff R, Edwards R, Li H, Manne K, Nicely N, et al. Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies. Cell. 2021;184:2955-2972.e25 pubmed 出版商
  27. Boelke M, Puff C, Becker K, Hellhammer F, Gusmag F, Marks H, et al. Enteric Ganglioneuritis, a Common Feature in a Subcutaneous TBEV Murine Infection Model. Microorganisms. 2021;9: pubmed 出版商
  28. Go D, Lee S, Lee S, Woo S, Kim K, Kim K, et al. Programmed Death Ligand 1-Expressing Classical Dendritic Cells MitigateHelicobacter-Induced Gastritis. Cell Mol Gastroenterol Hepatol. 2021;12:715-739 pubmed 出版商
  29. Mandolesi M, Sheward D, Hanke L, Ma J, Pushparaj P, Perez Vidakovics L, et al. SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responses. Cell Rep Med. 2021;2:100252 pubmed 出版商
  30. Pezzuto F, Lunardi F, Vedovelli L, Fortarezza F, Urso L, Grosso F, et al. P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment. Front Oncol. 2021;11:653497 pubmed 出版商
  31. Gómez Ferrer M, Villanueva Badenas E, Sánchez Sánchez R, Sánchez López C, Baquero M, Sepulveda P, et al. HIF-1α and Pro-Inflammatory Signaling Improves the Immunomodulatory Activity of MSC-Derived Extracellular Vesicles. Int J Mol Sci. 2021;22: pubmed 出版商
  32. Varona S, Puertas L, Galán M, Orriols M, Cañes L, Aguiló S, et al. Rolipram Prevents the Formation of Abdominal Aortic Aneurysm (AAA) in Mice: PDE4B as a Target in AAA. Antioxidants (Basel). 2021;10: pubmed 出版商
  33. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed 出版商
  34. Dejnirattisai W, Zhou D, Ginn H, Duyvesteyn H, Supasa P, Case J, et al. The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell. 2021;184:2183-2200.e22 pubmed 出版商
  35. Sewastianik T, Straubhaar J, Zhao J, Samur M, Adler K, Tanton H, et al. miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms. Blood. 2021;137:1905-1919 pubmed 出版商
  36. Brune M, Stussi G, Lundberg P, Vela V, Heim D, Manz M, et al. Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort. Ann Hematol. 2021;100:1169-1179 pubmed 出版商
  37. Belnoue E, Leystra A, Carboni S, Cooper H, Macedo R, Harvey K, et al. Novel Protein-Based Vaccine against Self-Antigen Reduces the Formation of Sporadic Colon Adenomas in Mice. Cancers (Basel). 2021;13: pubmed 出版商
  38. Choi Y, Kim Y, Oh S, Suh K, Kim Y, Lee G, et al. Senescent Tumor Cells Build a Cytokine Shield in Colorectal Cancer. Adv Sci (Weinh). 2021;8:2002497 pubmed 出版商
  39. Sokal A, Chappert P, Barba Spaeth G, Roeser A, Fourati S, Azzaoui I, et al. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell. 2021;184:1201-1213.e14 pubmed 出版商
  40. Biswas S, Mandal G, Payne K, Anadon C, Gatenbee C, Chaurio R, et al. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature. 2021;591:464-470 pubmed 出版商
  41. Mehta N, Li R, Zhang D, Soomro A, He J, Zhang I, et al. miR299a-5p promotes renal fibrosis by suppressing the antifibrotic actions of follistatin. Sci Rep. 2021;11:88 pubmed 出版商
  42. Webb L, Fra Bido S, Innocentin S, Matheson L, Attaf N, Bignon A, et al. Ageing promotes early T follicular helper cell differentiation by modulating expression of RBPJ. Aging Cell. 2021;20:e13295 pubmed 出版商
  43. Gregorova M, Morse D, Brignoli T, Steventon J, Hamilton F, Albur M, et al. Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. elife. 2020;9: pubmed 出版商
  44. Lund M, Howard C, Thurecht K, Campbell D, Mahler S, Walsh B. A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells. BMC Cancer. 2020;20:1214 pubmed 出版商
  45. Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184:169-183.e17 pubmed 出版商
  46. Tseng H, Xiong W, Badeti S, Yang Y, Ma M, Liu T, et al. Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma. Nat Commun. 2020;11:4810 pubmed 出版商
  47. Bhattacharya P, Ellegård R, Khalid M, Svanberg C, Govender M, Keita A, et al. Complement opsonization of HIV affects primary infection of human colorectal mucosa and subsequent activation of T cells. elife. 2020;9: pubmed 出版商
  48. Gawriluk T, Simkin J, Hacker C, Kimani J, Kiama S, Ezenwa V, et al. Complex Tissue Regeneration in Mammals Is Associated With Reduced Inflammatory Cytokines and an Influx of T Cells. Front Immunol. 2020;11:1695 pubmed 出版商
  49. Tan E, Hopkins R, Lim C, Jamuar S, Ong C, Thoon K, et al. Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency. J Clin Invest. 2020;130:5817-5832 pubmed 出版商
  50. Boettcher A, Cino Ozuna A, Solanki Y, Wiarda J, Putz E, Owens J, et al. CD3ε+ Cells in Pigs With Severe Combined Immunodeficiency Due to Defects in ARTEMIS. Front Immunol. 2020;11:510 pubmed 出版商
  51. Stebegg M, Bignon A, Hill D, Silva Cayetano A, Krueger C, Vanderleyden I, et al. Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination. elife. 2020;9: pubmed 出版商
  52. Kim J, Jeong J, Jung J, Jeon H, Lee S, Lim J, et al. Immunological characteristics and possible pathogenic role of urinary CD11c+ macrophages in lupus nephritis. Rheumatology (Oxford). 2020;: pubmed 出版商
  53. Crescitelli R, Lässer C, Jang S, Cvjetkovic A, Malmhäll C, Karimi N, et al. Subpopulations of extracellular vesicles from human metastatic melanoma tissue identified by quantitative proteomics after optimized isolation. J Extracell Vesicles. 2020;9:1722433 pubmed 出版商
  54. Hajaj E, Eisenberg G, Klein S, Frankenburg S, Merims S, Ben David I, et al. SLAMF6​ deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint. elife. 2020;9: pubmed 出版商
  55. Raehtz K, Barrenas F, Xu C, Busman Sahay K, Valentine A, Law L, et al. African green monkeys avoid SIV disease progression by preventing intestinal dysfunction and maintaining mucosal barrier integrity. PLoS Pathog. 2020;16:e1008333 pubmed 出版商
  56. Aslan K, Turco V, Blobner J, Sonner J, Liuzzi A, Núñez N, et al. Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas. Nat Commun. 2020;11:931 pubmed 出版商
  57. Chen H, Cong X, Wu C, Wu X, Wang J, Mao K, et al. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9+ T cells. Sci Adv. 2020;6:eaax4690 pubmed 出版商
  58. Bell L, Lenhart A, Rosenwald A, Monoranu C, Berberich Siebelt F. Lymphoid Aggregates in the CNS of Progressive Multiple Sclerosis Patients Lack Regulatory T Cells. Front Immunol. 2019;10:3090 pubmed 出版商
  59. Satpathy S, Jaehnig E, Krug K, Kim B, Saltzman A, Chan D, et al. Microscaled proteogenomic methods for precision oncology. Nat Commun. 2020;11:532 pubmed 出版商
  60. Cassidy L, Young A, Young C, Soilleux E, Fielder E, Weigand B, et al. Temporal inhibition of autophagy reveals segmental reversal of ageing with increased cancer risk. Nat Commun. 2020;11:307 pubmed 出版商
  61. Helmink B, Reddy S, Gao J, Zhang S, Basar R, Thakur R, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549-555 pubmed 出版商
  62. Shapiro M, Cheever T, Malherbe D, Pandey S, Reed J, Yang E, et al. Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunity. Nat Commun. 2020;11:70 pubmed 出版商
  63. Queckborner S, Syk Lundberg E, Gemzell Danielsson K, Davies L. Endometrial stromal cells exhibit a distinct phenotypic and immunomodulatory profile. Stem Cell Res Ther. 2020;11:15 pubmed 出版商
  64. Song S, Li Y, Zhang K, Zhang X, Huang Y, Xu M, et al. Cancer Stem Cells of Diffuse Large B Cell Lymphoma Are Not Enriched in the CD45+CD19- cells but in the ALDHhigh Cells. J Cancer. 2020;11:142-152 pubmed 出版商
  65. Le Nours J, Gherardin N, Ramarathinam S, Awad W, Wiede F, Gully B, et al. A class of γδ T cell receptors recognize the underside of the antigen-presenting molecule MR1. Science. 2019;366:1522-1527 pubmed 出版商
  66. Mantani P, Dunér P, Ljungcrantz I, Nilsson J, Bjorkbacka H, Fredrikson G. ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions. BMC Immunol. 2019;20:47 pubmed 出版商
  67. Shima T, Shimoda M, Shigenobu T, Ohtsuka T, Nishimura T, Emoto K, et al. Infiltration of tumor-associated macrophages is involved in tumor programmed death-ligand 1 expression in early lung adenocarcinoma. Cancer Sci. 2020;111:727-738 pubmed 出版商
  68. Calvanese V, Nguyen A, Bolan T, Vavilina A, Su T, Lee L, et al. MLLT3 governs human haematopoietic stem-cell self-renewal and engraftment. Nature. 2019;576:281-286 pubmed 出版商
  69. Ma A, Motyka B, Gutfreund K, Shi Y, George R. A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B. Hum Vaccin Immunother. 2020;16:756-778 pubmed 出版商
  70. Strickley J, Messerschmidt J, Awad M, Li T, Hasegawa T, Ha D, et al. Immunity to commensal papillomaviruses protects against skin cancer. Nature. 2019;: pubmed 出版商
  71. Ladinsky M, Khamaikawin W, Jung Y, Lin S, Lam J, An D, et al. Mechanisms of virus dissemination in bone marrow of HIV-1-infected humanized BLT mice. elife. 2019;8: pubmed 出版商
  72. Harel M, Ortenberg R, Varanasi S, Mangalhara K, Mardamshina M, Markovits E, et al. Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence. Cell. 2019;179:236-250.e18 pubmed 出版商
  73. Di Mascio M, Lifson J, Srinivasula S, Kim I, Degrange P, Keele B, et al. Evaluation of an antibody to α4β7 in the control of SIVmac239-nef-stop infection. Science. 2019;365:1025-1029 pubmed 出版商
  74. Martin J, Chang C, Boschetti G, Ungaro R, Giri M, Grout J, et al. Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell. 2019;178:1493-1508.e20 pubmed 出版商
  75. Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, et al. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Cell. 2019;178:795-806.e12 pubmed 出版商
  76. Banga R, Rebecchini C, Procopio F, Noto A, Munoz O, Ioannidou K, et al. Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement. PLoS Pathog. 2019;15:e1007918 pubmed 出版商
  77. Brook A, Jenkins R, Clayton A, Kift Morgan A, Raby A, Shephard A, et al. Neutrophil-derived miR-223 as local biomarker of bacterial peritonitis. Sci Rep. 2019;9:10136 pubmed 出版商
  78. Burel J, Pomaznoy M, Lindestam Arlehamn C, Weiskopf D, da Silva Antunes R, Jung Y, et al. Circulating T cell-monocyte complexes are markers of immune perturbations. elife. 2019;8: pubmed 出版商
  79. Pellin D, Loperfido M, Baricordi C, Wolock S, Montepeloso A, Weinberg O, et al. A comprehensive single cell transcriptional landscape of human hematopoietic progenitors. Nat Commun. 2019;10:2395 pubmed 出版商
  80. Gauthier L, Morel A, Anceriz N, Rossi B, Blanchard Alvarez A, Grondin G, et al. Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity. Cell. 2019;177:1701-1713.e16 pubmed 出版商
  81. Merve A, Zhang X, Pomella N, Acquati S, Hoeck J, Dumas A, et al. c-MYC overexpression induces choroid plexus papillomas through a T-cell mediated inflammatory mechanism. Acta Neuropathol Commun. 2019;7:2 pubmed 出版商
  82. Humeniuk P, Geiselhart S, Battin C, Webb T, Steinberger P, Paster W, et al. Generation of a Jurkat-based fluorescent reporter cell line to evaluate lipid antigen interaction with the human iNKT cell receptor. Sci Rep. 2019;9:7426 pubmed 出版商
  83. Swaims Kohlmeier A, Haddad L, Li Z, Brookmeyer K, Baker J, Widom C, et al. Chronic immune barrier dysregulation among women with a history of violence victimization. JCI Insight. 2019;4: pubmed 出版商
  84. Del Duca E, Pavel A, Dubin C, Song T, Wallace E, Peng X, et al. Major Differences in Expression of Inflammatory Pathways in Skin from Different Body Sites of Healthy Individuals. J Invest Dermatol. 2019;139:2228-2232.e10 pubmed 出版商
  85. Fernandez I, Baxter R, Garcia Perez J, Vendrame E, Ranganath T, Kong D, et al. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019;216:1255-1267 pubmed 出版商
  86. Yang W, Lee K, Srivastava R, Kuo F, Krishna C, Chowell D, et al. Immunogenic neoantigens derived from gene fusions stimulate T cell responses. Nat Med. 2019;25:767-775 pubmed 出版商
  87. Middha S, Yaeger R, Shia J, Stadler Z, King S, Guercio S, et al. Majority of B2M-Mutant and -Deficient Colorectal Carcinomas Achieve Clinical Benefit From Immune Checkpoint Inhibitor Therapy and Are Microsatellite Instability-High. JCO Precis Oncol. 2019;3: pubmed 出版商
  88. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed 出版商
  89. Lesch B, Tothova Z, Morgan E, Liao Z, Bronson R, Ebert B, et al. Intergenerational epigenetic inheritance of cancer susceptibility in mammals. elife. 2019;8: pubmed 出版商
  90. Dang A, Teles R, Weiss D, Parvatiyar K, Sarno E, Ochoa M, et al. IL-26 contributes to host defense against intracellular bacteria. J Clin Invest. 2019;129:1926-1939 pubmed 出版商
  91. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed 出版商
  92. Finney O, Brakke H, Rawlings Rhea S, Hicks R, Doolittle D, López M, et al. CD19 CAR T cell product and disease attributes predict leukemia remission durability. J Clin Invest. 2019;129:2123-2132 pubmed 出版商
  93. Banki Z, Krabbendam L, Klaver D, Leng T, Kruis S, Mehta H, et al. Antibody opsonization enhances MAIT cell responsiveness to bacteria via a TNF-dependent mechanism. Immunol Cell Biol. 2019;97:538-551 pubmed 出版商
  94. Kanomata N, Kurebayashi J, Koike Y, Yamaguchi R, Moriya T. CD1d- and PJA2-related immune microenvironment differs between invasive breast carcinomas with and without a micropapillary feature. BMC Cancer. 2019;19:76 pubmed 出版商
  95. Gerber D, Ghidinelli M, Tinelli E, Somandin C, Gerber J, Pereira J, et al. Schwann cells, but not Oligodendrocytes, Depend Strictly on Dynamin 2 Function. elife. 2019;8: pubmed 出版商
  96. Dagur R, Branch Woods A, Mathews S, Joshi P, Quadros R, Harms D, et al. Human-like NSG mouse glycoproteins sialylation pattern changes the phenotype of human lymphocytes and sensitivity to HIV-1 infection. BMC Immunol. 2019;20:2 pubmed 出版商
  97. Kumar A, Lee J, Suknuntha K, D Souza S, Thakur A, Slukvin I. NOTCH Activation at the Hematovascular Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells. J Immunol. 2019;202:770-776 pubmed 出版商
  98. Amelio P, Portevin D, Hella J, Reither K, Kamwela L, Lweno O, et al. HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses. J Virol. 2019;93: pubmed 出版商
  99. Chea L, Wyatt L, Gangadhara S, Moss B, Amara R. Novel Modified Vaccinia Virus Ankara Vector Expressing Anti-apoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses. J Virol. 2019;93: pubmed 出版商
  100. Andre P, Denis C, Soulas C, Bourbon Caillet C, Lopez J, Arnoux T, et al. Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells. Cell. 2018;175:1731-1743.e13 pubmed 出版商
  101. Williams P, Basu S, Garcia Manero G, Hourigan C, Oetjen K, Cortes J, et al. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer. 2019;125:1470-1481 pubmed 出版商
  102. Helmold Hait S, Vargas Inchaustegui D, Musich T, Mohanram V, Tuero I, Venzon D, et al. Early T Follicular Helper Cell Responses and Germinal Center Reactions Are Associated with Viremia Control in Immunized Rhesus Macaques. J Virol. 2019;93: pubmed 出版商
  103. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed 出版商
  104. Otsuka Y, Watanabe E, Shinya E, Okura S, Saeki H, Geijtenbeek T, et al. Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells. J Immunol. 2018;201:3006-3016 pubmed 出版商
  105. Hoang T, Harper J, Pino M, Wang H, Micci L, King C, et al. Bone Marrow-Derived CD4+ T Cells Are Depleted in Simian Immunodeficiency Virus-Infected Macaques and Contribute to the Size of the Replication-Competent Reservoir. J Virol. 2019;93: pubmed 出版商
  106. van Erp E, Feyaerts D, Duijst M, Mulder H, Wicht O, Luytjes W, et al. Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function. J Infect Dis. 2019;219:723-733 pubmed 出版商
  107. Sanyal R, Pavel A, Glickman J, Chan T, Zheng X, Zhang N, et al. Atopic dermatitis in African American patients is TH2/TH22-skewed with TH1/TH17 attenuation. Ann Allergy Asthma Immunol. 2019;122:99-110.e6 pubmed 出版商
  108. Watanabe N, Takaku T, Takeda K, Shirane S, Toyota T, Koike M, et al. Dasatinib-induced anti-leukemia cellular immunity through a novel subset of CD57 positive helper/cytotoxic CD4 T cells in chronic myelogenous leukemia patients. Int J Hematol. 2018;108:588-597 pubmed 出版商
  109. Tai Y, Lin L, Xing L, Cho S, Yu T, Acharya C, et al. APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications. Leukemia. 2019;33:426-438 pubmed 出版商
  110. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed 出版商
  111. Cuchet Lourenço D, Eletto D, Wu C, Plagnol V, Papapietro O, CURTIS J, et al. Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation. Science. 2018;361:810-813 pubmed 出版商
  112. Levin M, Kroehl M, Johnson M, Hammes A, Reinhold D, Lang N, et al. Th1 memory differentiates recombinant from live herpes zoster vaccines. J Clin Invest. 2018;128:4429-4440 pubmed 出版商
  113. Pratt D, Dominah G, Lobel G, Obungu A, Lynes J, Sanchez V, et al. Programmed Death Ligand 1 Is a Negative Prognostic Marker in Recurrent Isocitrate Dehydrogenase-Wildtype Glioblastoma. Neurosurgery. 2018;: pubmed 出版商
  114. Desimio M, Giuliani E, Ferraro A, Adorno G, Doria M. In Vitro Exposure to Prostratin but Not Bryostatin-1 Improves Natural Killer Cell Functions Including Killing of CD4+ T Cells Harboring Reactivated Human Immunodeficiency Virus. Front Immunol. 2018;9:1514 pubmed 出版商
  115. Voigt J, Malone D, Dias J, Leeansyah E, Björkström N, Ljunggren H, et al. Proteome analysis of human CD56neg NK cells reveals a homogeneous phenotype surprisingly similar to CD56dim NK cells. Eur J Immunol. 2018;48:1456-1469 pubmed 出版商
  116. Yang X, Zhou J, He J, Liu J, Wang H, Liu Y, et al. An Immune System-Modified Rat Model for Human Stem Cell Transplantation Research. Stem Cell Reports. 2018;11:514-521 pubmed 出版商
  117. Heusinger E, Deppe K, Sette P, Krapp C, Kmiec D, Kluge S, et al. Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2. J Virol. 2018;92: pubmed 出版商
  118. Jung I, Kim Y, Yu H, Lee M, Kim S, Lee J. CRISPR/Cas9-Mediated Knockout of DGK Improves Antitumor Activities of Human T Cells. Cancer Res. 2018;78:4692-4703 pubmed 出版商
  119. Capuano C, Battella S, Pighi C, Franchitti L, Turriziani O, Morrone S, et al. Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming. Front Immunol. 2018;9:1031 pubmed 出版商
  120. Dorraji S, Hovd A, Kanapathippillai P, Bakland G, Eilertsen G, Figenschau S, et al. Mesenchymal stem cells and T cells in the formation of Tertiary Lymphoid Structures in Lupus Nephritis. Sci Rep. 2018;8:7861 pubmed 出版商
  121. Sayin I, Radtke A, Vella L, Jin W, Wherry E, Buggert M, et al. Spatial distribution and function of T follicular regulatory cells in human lymph nodes. J Exp Med. 2018;215:1531-1542 pubmed 出版商
  122. Sullivan N, Reuter Monslow M, Sei J, Durr E, Davis C, Chang C, et al. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans. J Virol. 2018;92: pubmed 出版商
  123. Manickam C, Nwanze C, Ram D, Shah S, Smith S, Jones R, et al. Progressive lentivirus infection induces natural killer cell receptor-expressing B cells in the gastrointestinal tract. AIDS. 2018;32:1571-1578 pubmed 出版商
  124. Ferrando Martinez S, Moysi E, Pegu A, Andrews S, Nganou Makamdop K, Ambrozak D, et al. Accumulation of follicular CD8+ T cells in pathogenic SIV infection. J Clin Invest. 2018;128:2089-2103 pubmed 出版商
  125. Shi Y, Zhang P, Wang G, Liu X, Sun X, Zhang X, et al. Description of organ-specific phenotype, and functional characteristics of tissue resident lymphocytes from liver transplantation donor and research on immune tolerance mechanism of liver. Oncotarget. 2018;9:15552-15565 pubmed 出版商
  126. Lee C, Moon S, Jeong J, Lee S, Lee M, Yoo S, et al. Kaempferol targeting on the fibroblast growth factor receptor 3-ribosomal S6 kinase 2 signaling axis prevents the development of rheumatoid arthritis. Cell Death Dis. 2018;9:401 pubmed 出版商
  127. Messlinger H, Sebald H, Heger L, Dudziak D, Bogdan C, Schleicher U. Monocyte-Derived Signals Activate Human Natural Killer Cells in Response to Leishmania Parasites. Front Immunol. 2018;9:24 pubmed 出版商
  128. Linehan J, Harrison O, Han S, Byrd A, Vujkovic Cvijin I, Villarino A, et al. Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair. Cell. 2018;172:784-796.e18 pubmed 出版商
  129. Tissino E, Benedetti D, Herman S, ten Hacken E, Ahn I, Chaffee K, et al. Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia. J Exp Med. 2018;215:681-697 pubmed 出版商
  130. Gee M, Han A, Lofgren S, Beausang J, Mendoza J, Birnbaum M, et al. Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell. 2018;172:549-563.e16 pubmed 出版商
  131. Pugh J, Nemat Gorgani N, Norman P, Guethlein L, Parham P. Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage. J Immunol. 2018;200:1146-1158 pubmed 出版商
  132. Amodio D, Cotugno N, Macchiarulo G, Rocca S, Dimopoulos Y, Castrucci M, et al. Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza Vaccination. J Immunol. 2018;200:538-550 pubmed 出版商
  133. Jasinski Bergner S, Büttner M, Quandt D, Seliger B, Kielstein H. Adiponectin and Its Receptors Are Differentially Expressed in Human Tissues and Cell Lines of Distinct Origin. Obes Facts. 2017;10:569-583 pubmed 出版商
  134. Fry T, Shah N, Orentas R, Stetler Stevenson M, Yuan C, Ramakrishna S, et al. CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy. Nat Med. 2018;24:20-28 pubmed 出版商
  135. Schwartz J, Ma J, Lamprecht T, Walsh M, Wang S, Bryant V, et al. The genomic landscape of pediatric myelodysplastic syndromes. Nat Commun. 2017;8:1557 pubmed 出版商
  136. Moreno Cubero E, Subira D, Sanz de Villalobos E, Parra Cid T, Madejon A, Miquel J, et al. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity. J Virol. 2018;92: pubmed 出版商
  137. Jeong J, Hong S, Kwon O, Ghang B, Hwang I, Kim Y, et al. CD14+ Cells with the Phenotype of Infiltrated Monocytes Consist of Distinct Populations Characterized by Anti-inflammatory as well as Pro-inflammatory Activity in Gouty Arthritis. Front Immunol. 2017;8:1260 pubmed 出版商
  138. Arthur Huang K, Chen M, Huang Y, Shih S, Chiu C, Lin J, et al. Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children. Nat Commun. 2017;8:762 pubmed 出版商
  139. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed 出版商
  140. Salio M, Gasser O, González López C, Martens A, Veerapen N, Gileadi U, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017;199:2631-2638 pubmed 出版商
  141. Pinaud L, Samassa F, Porat Z, Ferrari M, Belotserkovsky I, Parsot C, et al. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes. Proc Natl Acad Sci U S A. 2017;114:9954-9959 pubmed 出版商
  142. Patel S, Sanjana N, Kishton R, Eidizadeh A, Vodnala S, Cam M, et al. Identification of essential genes for cancer immunotherapy. Nature. 2017;548:537-542 pubmed 出版商
  143. Codreanu S, Hoeksema M, Slebos R, Zimmerman L, Rahman S, Li M, et al. Identification of Proteomic Features To Distinguish Benign Pulmonary Nodules from Lung Adenocarcinoma. J Proteome Res. 2017;16:3266-3276 pubmed 出版商
  144. Gorvel L, Korenfeld D, Tung T, Klechevsky E. Dendritic Cell-Derived IL-32?: A Novel Inhibitory Cytokine of NK Cell Function. J Immunol. 2017;199:1290-1300 pubmed 出版商
  145. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete P, Gonzalez Figueroa P, et al. TFH-derived dopamine accelerates productive synapses in germinal centres. Nature. 2017;547:318-323 pubmed 出版商
  146. Sugimura R, Jha D, Han A, Soria Valles C, da Rocha E, Lu Y, et al. Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature. 2017;545:432-438 pubmed 出版商
  147. Roy A, Attarha S, Weishaupt H, Edqvist P, Swartling F, Bergqvist M, et al. Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression. Oncotarget. 2017;8:24815-24827 pubmed 出版商
  148. Ma S, Imadojemu S, Beer K, Seykora J. Inflammatory features of frontal fibrosing alopecia. J Cutan Pathol. 2017;44:672-676 pubmed 出版商
  149. Angelin A, Gil de Gómez L, Dahiya S, Jiao J, Guo L, Levine M, et al. Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments. Cell Metab. 2017;25:1282-1293.e7 pubmed 出版商
  150. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed 出版商
  151. Stevanović S, Pasetto A, Helman S, Gartner J, Prickett T, Howie B, et al. Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer. Science. 2017;356:200-205 pubmed 出版商
  152. Gaggianesi M, Turdo A, Chinnici A, Lipari E, Apuzzo T, Benfante A, et al. IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition. Cancer Res. 2017;77:3268-3279 pubmed 出版商
  153. Zanin Zhorov A, Weiss J, Trzeciak A, Chen W, Zhang J, Nyuydzefe M, et al. Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10. J Immunol. 2017;198:3809-3814 pubmed 出版商
  154. Cooper A, Lill G, Shaw K, Carbonaro Sarracino D, Davila A, Sokolic R, et al. Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients. Blood. 2017;129:2624-2635 pubmed 出版商
  155. Chang K, Smith S, Sullivan T, Chen K, Zhou Q, West J, et al. Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34+ Hematopoietic Stem and Progenitor Cells. Mol Ther Methods Clin Dev. 2017;4:137-148 pubmed 出版商
  156. Miyata Takata T, Takata K, Kato S, Hu L, Noujima Harada M, Chuang S, et al. Clinicopathological analysis of primary central nervous system NK/T cell lymphoma: rare and localized aggressive tumour among extranasal NK/T cell tumours. Histopathology. 2017;71:287-295 pubmed 出版商
  157. van der Velden V, Flores Montero J, Perez Andres M, Martin Ayuso M, Crespo O, Blanco E, et al. Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples. J Immunol Methods. 2017;: pubmed 出版商
  158. Bergström I, Lundberg A, Jonsson S, Särndahl E, Ernerudh J, Jonasson L. Annexin A1 in blood mononuclear cells from patients with coronary artery disease: Its association with inflammatory status and glucocorticoid sensitivity. PLoS ONE. 2017;12:e0174177 pubmed 出版商
  159. Descours B, Petitjean G, López Zaragoza J, Bruel T, Raffel R, Psomas C, et al. CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses. Nature. 2017;543:564-567 pubmed 出版商
  160. Nishimura Y, Gautam R, Chun T, Sadjadpour R, Foulds K, Shingai M, et al. Early antibody therapy can induce long-lasting immunity to SHIV. Nature. 2017;543:559-563 pubmed 出版商
  161. Li R, Rezk A, Li H, Gommerman J, Prat A, Bar Or A. Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses. J Immunol. 2017;198:3245-3254 pubmed 出版商
  162. Perander M, Al Mahdi R, Jensen T, Nunn J, Kildalsen H, Johansen B, et al. Regulation of atypical MAP kinases ERK3 and ERK4 by the phosphatase DUSP2. Sci Rep. 2017;7:43471 pubmed 出版商
  163. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed 出版商
  164. Wouters K, Gaens K, Bijnen M, Verboven K, Jocken J, Wetzels S, et al. Circulating classical monocytes are associated with CD11c+ macrophages in human visceral adipose tissue. Sci Rep. 2017;7:42665 pubmed 出版商
  165. Perez Ruiz de Garibay A, Spinato C, Klippstein R, Bourgognon M, Martincic M, Pach E, et al. Evaluation of the immunological profile of antibody-functionalized metal-filled single-walled carbon nanocapsules for targeted radiotherapy. Sci Rep. 2017;7:42605 pubmed 出版商
  166. Watanabe N, Bajgain P, Sukumaran S, Ansari S, Heslop H, Rooney C, et al. Fine-tuning the CAR spacer improves T-cell potency. Oncoimmunology. 2016;5:e1253656 pubmed 出版商
  167. Jeffery H, Jeffery L, Lutz P, Corrigan M, Webb G, Hirschfield G, et al. Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases. Clin Exp Immunol. 2017;188:394-411 pubmed 出版商
  168. O CONNOR D, Clutterbuck E, Thompson A, Snape M, Ramasamy M, Kelly D, et al. High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine. Genome Med. 2017;9:11 pubmed 出版商
  169. Berlato C, Khan M, Schioppa T, Thompson R, Maniati E, Montfort A, et al. A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer. J Clin Invest. 2017;127:801-813 pubmed 出版商
  170. Hammonds J, Beeman N, Ding L, Takushi S, Francis A, Wang J, et al. Siglec-1 initiates formation of the virus-containing compartment and enhances macrophage-to-T cell transmission of HIV-1. PLoS Pathog. 2017;13:e1006181 pubmed 出版商
  171. Vähätupa M, Aittomaki S, Martinez Cordova Z, May U, Prince S, Uusitalo Jarvinen H, et al. T-cell-expressed proprotein convertase FURIN inhibits DMBA/TPA-induced skin cancer development. Oncoimmunology. 2016;5:e1245266 pubmed 出版商
  172. Salvatori G, Foligno S, Sirleto P, Genovese S, Russo S, Coletti V, et al. Sometimes it is better to wait: First Italian case of a newborn with transient abnormal myelopoiesis and a favorable prognosis. Oncol Lett. 2017;13:191-195 pubmed 出版商
  173. Wentink M, Dalm V, Lankester A, van Schouwenburg P, Schölvinck L, Kalina T, et al. Genetic defects in PI3K? affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. Clin Immunol. 2017;176:77-86 pubmed 出版商
  174. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed 出版商
  175. Wonderlich E, Swan Z, Bissel S, Hartman A, Carney J, O Malley K, et al. Widespread Virus Replication in Alveoli Drives Acute Respiratory Distress Syndrome in Aerosolized H5N1 Influenza Infection of Macaques. J Immunol. 2017;198:1616-1626 pubmed 出版商
  176. Bolzoni M, Ronchetti D, Storti P, Donofrio G, Marchica V, Costa F, et al. IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts. Haematologica. 2017;102:773-784 pubmed 出版商
  177. Guicciardi M, Krishnan A, Bronk S, Hirsova P, Griffith T, Gores G. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice. Cell Death Dis. 2017;8:e2535 pubmed 出版商
  178. Roberts E, Carnathan D, Li H, Shaw G, Silvestri G, Betts M. Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques. PLoS Pathog. 2016;12:e1006135 pubmed 出版商
  179. Stanfield B, Pahar B, Chouljenko V, Veazey R, Kousoulas K. Vaccination of rhesus macaques with the live-attenuated HSV-1 vaccine VC2 stimulates the proliferation of mucosal T cells and germinal center responses resulting in sustained production of highly neutralizing antibodies. Vaccine. 2017;35:536-543 pubmed 出版商
  180. Jerić I, Maurer G, Cavallo A, Raguz J, Desideri E, Tarkowski B, et al. A cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesis. Nat Commun. 2016;7:13781 pubmed 出版商
  181. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed 出版商
  182. Dross S, Munson P, Kim S, Bratt D, Tunggal H, Gervassi A, et al. Kinetics of Myeloid-Derived Suppressor Cell Frequency and Function during Simian Immunodeficiency Virus Infection, Combination Antiretroviral Therapy, and Treatment Interruption. J Immunol. 2017;198:757-766 pubmed 出版商
  183. Sairafi D, Stikvoort A, Gertow J, Mattsson J, Uhlin M. Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. J Immunol Res. 2016;2016:5601204 pubmed
  184. Lévy R, Okada S, Béziat V, Moriya K, Liu C, Chai L, et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci U S A. 2016;113:E8277-E8285 pubmed 出版商
  185. Ng S, Mitchell A, Kennedy J, Chen W, McLeod J, Ibrahimova N, et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016;540:433-437 pubmed 出版商
  186. Ribeiro C, Sarrami Forooshani R, Setiawan L, Zijlstra Willems E, van Hamme J, Tigchelaar W, et al. Receptor usage dictates HIV-1 restriction by human TRIM5? in dendritic cell subsets. Nature. 2016;540:448-452 pubmed 出版商
  187. Cecchinato V, Bernasconi E, Speck R, Proietti M, Sauermann U, D Agostino G, et al. Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization. J Immunol. 2017;198:184-195 pubmed
  188. Snyder Mackler N, Sanz J, Kohn J, Brinkworth J, Morrow S, Shaver A, et al. Social status alters immune regulation and response to infection in macaques. Science. 2016;354:1041-1045 pubmed
  189. Siegers G, Barreira C, Postovit L, Dekaban G. CD11d ?2 integrin expression on human NK, B, and ?? T cells. J Leukoc Biol. 2017;101:1029-1035 pubmed 出版商
  190. Hippen K, Watkins B, Tkachev V, Lemire A, Lehnen C, Riddle M, et al. Preclinical Testing of Antihuman CD28 Fab' Antibody in a Novel Nonhuman Primate Small Animal Rodent Model of Xenogenic Graft-Versus-Host Disease. Transplantation. 2016;100:2630-2639 pubmed 出版商
  191. Sundara Y, Kostine M, Cleven A, Bovee J, Schilham M, Cleton Jansen A. Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy. Cancer Immunol Immunother. 2017;66:119-128 pubmed 出版商
  192. Li J, Shayan G, Avery L, Jie H, Gildener Leapman N, Schmitt N, et al. Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk. Oncoimmunology. 2016;5:e1200778 pubmed
  193. Ju X, Silveira P, Hsu W, Elgundi Z, Alingcastre R, Verma N, et al. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population. J Immunol. 2016;197:4613-4625 pubmed
  194. Cheeseman H, Olejniczak N, Rogers P, Evans A, King D, Ziprin P, et al. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies. J Virol. 2017;91: pubmed 出版商
  195. Adair J, Waters T, Haworth K, Kubek S, Trobridge G, Hocum J, et al. Semi-automated closed system manufacturing of lentivirus gene-modified haematopoietic stem cells for gene therapy. Nat Commun. 2016;7:13173 pubmed 出版商
  196. Byrareddy S, Arthos J, Cicala C, Villinger F, Ortiz K, Little D, et al. Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy. Science. 2016;354:197-202 pubmed
  197. Osterburg A, Nelson R, Yaniv B, Foot R, Donica W, Nashu M, et al. NK cell activating receptor ligand expression in lymphangioleiomyomatosis is associated with lung function decline. JCI Insight. 2016;1:e87270 pubmed 出版商
  198. Gabanti E, Bruno F, Scaramuzzi L, Mangione F, Zelini P, Gerna G, et al. Predictive value of human cytomegalovirus (HCMV) T-cell response in the control of HCMV infection by seropositive solid-organ transplant recipients according to different assays and stimuli. New Microbiol. 2016;39:247-258 pubmed
  199. Miles B, Miller S, Folkvord J, Levy D, Rakasz E, Skinner P, et al. Follicular Regulatory CD8 T Cells Impair the Germinal Center Response in SIV and Ex Vivo HIV Infection. PLoS Pathog. 2016;12:e1005924 pubmed 出版商
  200. Oon S, Huynh H, Tai T, Ng M, Monaghan K, Biondo M, et al. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight. 2016;1:e86131 pubmed 出版商
  201. Lu L, Chung A, Rosebrock T, Ghebremichael M, Yu W, Grace P, et al. A Functional Role for Antibodies in Tuberculosis. Cell. 2016;167:433-443.e14 pubmed 出版商
  202. Willemen Y, Van den Bergh J, Bonte S, Anguille S, Heirman C, Stein B, et al. The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells. Oncotarget. 2016;7:73960-73970 pubmed 出版商
  203. Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
  204. Roncagalli R, Cucchetti M, Jarmuzynski N, Gregoire C, Bergot E, Audebert S, et al. The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells. J Exp Med. 2016;213:2437-2457 pubmed
  205. Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O, et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016;167:203-218.e17 pubmed 出版商
  206. Wahid R, Fresnay S, Levine M, Sztein M. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a. Clin Immunol. 2016;173:87-95 pubmed 出版商
  207. Foerster F, Bamberger D, Schupp J, Weilbächer M, Kaps L, Strobl S, et al. Dextran-based therapeutic nanoparticles for hepatic drug delivery. Nanomedicine (Lond). 2016;11:2663-2677 pubmed
  208. Hoehne S, McDonough S, Rishniw M, Simpson K. Identification of Mucosa-Invading and Intravascular Bacteria in Feline Small Intestinal Lymphoma. Vet Pathol. 2017;54:234-241 pubmed 出版商
  209. Di Blasio S, Wortel I, van Bladel D, de Vries L, Duiveman de Boer T, Worah K, et al. Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death. Oncoimmunology. 2016;5:e1192739 pubmed 出版商
  210. Kelly A, Robinson M, Roche G, Biron C, O Farrelly C, Ryan E. Immune Cell Profiling of IFN-? Response Shows pDCs Express Highest Level of IFN-?R1 and Are Directly Responsive via the JAK-STAT Pathway. J Interferon Cytokine Res. 2016;36:671-680 pubmed
  211. Tang M, Reedquist K, Garcia S, Fernandez B, Codullo V, Vieira Sousa E, et al. The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation. Rheumatology (Oxford). 2016;55:2248-2259 pubmed
  212. Schmidt A, Kannan P, Chougnet C, Danzer S, Miller L, Jobe A, et al. Intra-amniotic LPS causes acute neuroinflammation in preterm rhesus macaques. J Neuroinflammation. 2016;13:238 pubmed 出版商
  213. Zenarruzabeitia O, Vitallé J, Garcia Obregon S, Astigarraga I, Eguizabal C, Santos S, et al. The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults. Sci Rep. 2016;6:32693 pubmed 出版商
  214. Ferre E, Rose S, Rosenzweig S, Burbelo P, Romito K, Niemela J, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016;1: pubmed
  215. Ilkovitch D, Ferris L. Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules. Mol Med Rep. 2016;14:3935-40 pubmed 出版商
  216. Muller Durovic B, Lanna A, Covre L, Mills R, Henson S, Akbar A. Killer Cell Lectin-like Receptor G1 Inhibits NK Cell Function through Activation of Adenosine 5'-Monophosphate-Activated Protein Kinase. J Immunol. 2016;197:2891-2899 pubmed 出版商
  217. Ayala V, Trivett M, Barsov E, Jain S, Piatak M, Trubey C, et al. Adoptive Transfer of Engineered Rhesus Simian Immunodeficiency Virus-Specific CD8+ T Cells Reduces the Number of Transmitted/Founder Viruses Established in Rhesus Macaques. J Virol. 2016;90:9942-9952 pubmed 出版商
  218. Chuang H, Chen Y, Hung W, Li J, Chen D, Lan J, et al. Downregulation of the phosphatase JKAP/DUSP22 in T cells as a potential new biomarker of systemic lupus erythematosus nephritis. Oncotarget. 2016;7:57593-57605 pubmed 出版商
  219. Kmiec D, Iyer S, Stürzel C, Sauter D, Hahn B, Kirchhoff F. Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance. MBio. 2016;7: pubmed 出版商
  220. Hoare M, Ito Y, Kang T, Weekes M, Matheson N, Patten D, et al. NOTCH1 mediates a switch between two distinct secretomes during senescence. Nat Cell Biol. 2016;18:979-92 pubmed 出版商
  221. Watson D, Bayık D, Srivatsan A, Bergamaschi C, Valentin A, Niu G, et al. Efficient production and enhanced tumor delivery of engineered extracellular vesicles. Biomaterials. 2016;105:195-205 pubmed 出版商
  222. Bronger H, Singer J, Windmüller C, Reuning U, Zech D, Delbridge C, et al. CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer. Br J Cancer. 2016;115:553-63 pubmed 出版商
  223. Godinho Santos A, Hance A, Gonçalves J, Mammano F. CIB1 and CIB2 are HIV-1 helper factors involved in viral entry. Sci Rep. 2016;6:30927 pubmed 出版商
  224. Cerny D, Thi Le D, The T, Zuest R, Kg S, Velumani S, et al. Complete human CD1a deficiency on Langerhans cells due to a rare point mutation in the coding sequence. J Allergy Clin Immunol. 2016;138:1709-1712.e11 pubmed 出版商
  225. Paquin Proulx D, Gibbs A, Bachle S, Checa A, Introini A, Leeansyah E, et al. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion. J Immunol. 2016;197:1843-51 pubmed 出版商
  226. Debliquis A, Voirin J, Harzallah I, Maurer M, Lerintiu F, Drenou B, et al. Cytomorphology and flow cytometry of brain biopsy rinse fluid enables faster and multidisciplinary diagnosis of large B-cell lymphoma of the central nervous system. Cytometry B Clin Cytom. 2018;94:182-188 pubmed 出版商
  227. Chen H, Händel N, Ngeow J, Muller J, Huhn M, Yang H, et al. Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells. J Allergy Clin Immunol. 2017;139:607-620.e15 pubmed 出版商
  228. Miyan M, Schmidt Mende J, Kiessling R, Poschke I, de Boniface J. Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer. J Transl Med. 2016;14:227 pubmed 出版商
  229. Neumann L, Mueller M, Moos V, Heller F, Meyer T, Loddenkemper C, et al. Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients. J Immunol. 2016;197:1801-8 pubmed 出版商
  230. DeGottardi M, Okoye A, Vaidya M, Talla A, Konfe A, Reyes M, et al. Effect of Anti-IL-15 Administration on T Cell and NK Cell Homeostasis in Rhesus Macaques. J Immunol. 2016;197:1183-98 pubmed 出版商
  231. Fromentin R, Bakeman W, Lawani M, Khoury G, Hartogensis W, DaFonseca S, et al. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART. PLoS Pathog. 2016;12:e1005761 pubmed 出版商
  232. Cox A, Barrandon O, Cai E, Rios J, Chavez J, Bonnyman C, et al. Resolving Discrepant Findings on ANGPTL8 in ?-Cell Proliferation: A Collaborative Approach to Resolving the Betatrophin Controversy. PLoS ONE. 2016;11:e0159276 pubmed 出版商
  233. Di Liberto D, Mansueto P, D Alcamo A, Lo Pizzo M, Lo Presti E, Geraci G, et al. Predominance of Type 1 Innate Lymphoid Cells in the Rectal Mucosa of Patients With Non-Celiac Wheat Sensitivity: Reversal After a Wheat-Free Diet. Clin Transl Gastroenterol. 2016;7:e178 pubmed 出版商
  234. Ellebrecht C, Bhoj V, Nace A, Choi E, Mao X, Cho M, et al. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. Science. 2016;353:179-84 pubmed 出版商
  235. Williams D, Engle E, Shirk E, Queen S, Gama L, Mankowski J, et al. Splenic Damage during SIV Infection: Role of T-Cell Depletion and Macrophage Polarization and Infection. Am J Pathol. 2016;186:2068-2087 pubmed 出版商
  236. Fu T, Yang W, Zhang X, Xu X. Peripheral T-cell lymphoma unspecified type presenting with a pneumothorax as the initial manifestation: A case report and literature review. Oncol Lett. 2016;11:4069-4076 pubmed
  237. Chen P, Roh W, Reuben A, Cooper Z, Spencer C, Prieto P, et al. Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade. Cancer Discov. 2016;6:827-37 pubmed 出版商
  238. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed 出版商
  239. Xu Y, Chaudhury A, Zhang M, Savoldo B, Metelitsa L, Rodgers J, et al. Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. J Clin Invest. 2016;126:2678-88 pubmed 出版商
  240. Domingues R, de Carvalho G, Aoki V, da Silva Duarte A, Sato M. Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus. J Transl Med. 2016;14:171 pubmed 出版商
  241. Ramos C, Savoldo B, Torrano V, Ballard B, Zhang H, Dakhova O, et al. Clinical responses with T lymphocytes targeting malignancy-associated ? light chains. J Clin Invest. 2016;126:2588-96 pubmed 出版商
  242. Najjar A, Manuri P, Olivares S, Flores L, Mi T, Huls H, et al. Imaging of Sleeping Beauty-Modified CD19-Specific T Cells Expressing HSV1-Thymidine Kinase by Positron Emission Tomography. Mol Imaging Biol. 2016;18:838-848 pubmed
  243. van der Heiden M, van Zelm M, Bartol S, de Rond L, Berbers G, Boots A, et al. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci Rep. 2016;6:26892 pubmed 出版商
  244. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed 出版商
  245. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed 出版商
  246. Kwon H, Choi G, Ryu S, Kwon S, Kim S, Booth C, et al. Stepwise phosphorylation of p65 promotes NF-?B activation and NK cell responses during target cell recognition. Nat Commun. 2016;7:11686 pubmed 出版商
  247. Reinisch A, Thomas D, Corces M, Zhang X, Gratzinger D, Hong W, et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat Med. 2016;22:812-21 pubmed 出版商
  248. Shono Y, Docampo M, Peled J, Perobelli S, Velardi E, Tsai J, et al. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med. 2016;8:339ra71 pubmed 出版商
  249. Gren S, Janciauskiene S, Sandeep S, Jonigk D, Kvist P, Gerwien J, et al. The protease inhibitor cystatin C down-regulates the release of IL-? and TNF-? in lipopolysaccharide activated monocytes. J Leukoc Biol. 2016;100:811-822 pubmed
  250. Dou D, Calvanese V, Sierra M, Nguyen A, Minasian A, Saarikoski P, et al. Medial HOXA genes demarcate haematopoietic stem cell fate during human development. Nat Cell Biol. 2016;18:595-606 pubmed 出版商
  251. Marafini I, Monteleone I, Di Fusco D, Sedda S, Cupi M, Fina D, et al. Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells. PLoS ONE. 2016;11:e0155103 pubmed 出版商
  252. Stikvoort A, Sundin M, Uzunel M, Gertow J, Sundberg B, Schaffer M, et al. Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?. PLoS ONE. 2016;11:e0154737 pubmed 出版商
  253. Tuşaliu M, Zainea V, Mogoantă C, Dragu A, GoanŢă C, Niţescu M, et al. Diagnostic and therapeutic aspects in malignant sinonasal lymphoma. Rom J Morphol Embryol. 2016;57:233-6 pubmed
  254. Cook A, McDonnell A, Lake R, Nowak A. Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. Oncoimmunology. 2016;5:e1066062 pubmed
  255. Mizutani N, Goto Koshino Y, Takahashi M, Uchida K, Tsujimoto H. Clinical and histopathological evaluation of 16 dogs with T-zone lymphoma. J Vet Med Sci. 2016;78:1237-44 pubmed 出版商
  256. Siddiqui I, Erreni M, van Brakel M, Debets R, Allavena P. Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient. J Immunother Cancer. 2016;4:21 pubmed 出版商
  257. Mizutani N, Goto Koshino Y, Tsuboi M, Kagawa Y, Ohno K, Uchida K, et al. Evaluation of CD25-positive cells in relation to the subtypes and prognoses in various lymphoid tumours in dogs. Vet Immunol Immunopathol. 2016;173:39-43 pubmed 出版商
  258. Yamashita K, Kawata K, Matsumiya H, Kamekura R, Jitsukawa S, Nagaya T, et al. Bob1 limits cellular frequency of T-follicular helper cells. Eur J Immunol. 2016;46:1361-70 pubmed 出版商
  259. Zurawski G, Zurawski S, Flamar A, Richert L, Wagner R, Tomaras G, et al. Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques. PLoS ONE. 2016;11:e0153484 pubmed 出版商
  260. Komori M, Lin Y, Cortese I, Blake A, Ohayon J, Cherup J, et al. Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis. Ann Clin Transl Neurol. 2016;3:166-79 pubmed 出版商
  261. Rueda C, Presicce P, Jackson C, Miller L, Kallapur S, Jobe A, et al. Lipopolysaccharide-Induced Chorioamnionitis Promotes IL-1-Dependent Inflammatory FOXP3+ CD4+ T Cells in the Fetal Rhesus Macaque. J Immunol. 2016;196:3706-15 pubmed 出版商
  262. Carrasco A, Fernández Bañares F, Pedrosa E, Salas A, Loras C, Rosinach M, et al. Regional Specialisation of T Cell Subsets and Apoptosis in the Human Gut Mucosa: Differences Between Ileum and Colon in Healthy Intestine and Inflammatory Bowel Diseases. J Crohns Colitis. 2016;10:1042-54 pubmed 出版商
  263. van Kempen P, Noorlag R, Swartz J, Bovenschen N, Braunius W, Vermeulen J, et al. Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors. Cancer Immunol Immunother. 2016;65:575-85 pubmed 出版商
  264. Galán M, Varona S, Orriols M, Rodríguez J, Aguiló S, Dilmé J, et al. Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors. Dis Model Mech. 2016;9:541-52 pubmed 出版商
  265. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  266. Vermeulen J, Van Hecke W, Spliet W, Villacorta Hidalgo J, Fisch P, Broekhuizen R, et al. Pediatric Primitive Neuroectodermal Tumors of the Central Nervous System Differentially Express Granzyme Inhibitors. PLoS ONE. 2016;11:e0151465 pubmed 出版商
  267. Mertz K, Mager L, Wasmer M, Thiesler T, Koelzer V, Ruzzante G, et al. The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice. Oncoimmunology. 2016;5:e1062966 pubmed
  268. Gao J, Duan Z, Zhang L, Huang X, Long L, Tu J, et al. Failure recovery of circulating NKG2D+CD56dimNK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence. Oncoimmunology. 2016;5:e1048061 pubmed
  269. Carrasco A, Esteve M, Salas A, Pedrosa E, Rosinach M, Aceituno M, et al. Immunological Differences between Lymphocytic and Collagenous Colitis. J Crohns Colitis. 2016;10:1055-66 pubmed 出版商
  270. Hogan L, Jones D, Allen R. Expression of the innate immune receptor LILRB5 on monocytes is associated with mycobacteria exposure. Sci Rep. 2016;6:21780 pubmed 出版商
  271. Phuah J, Wong E, Gideon H, Maiello P, Coleman M, Hendricks M, et al. Effects of B Cell Depletion on Early Mycobacterium tuberculosis Infection in Cynomolgus Macaques. Infect Immun. 2016;84:1301-1311 pubmed 出版商
  272. Delcambre G, Liu J, Herrington J, Vallario K, Long M. Immunohistochemistry for the detection of neural and inflammatory cells in equine brain tissue. Peerj. 2016;4:e1601 pubmed 出版商
  273. Garcia Bates T, Kim E, Concha Benavente F, Trivedi S, Mailliard R, Gambotto A, et al. Enhanced Cytotoxic CD8 T Cell Priming Using Dendritic Cell-Expressing Human Papillomavirus-16 E6/E7-p16INK4 Fusion Protein with Sequenced Anti-Programmed Death-1. J Immunol. 2016;196:2870-8 pubmed 出版商
  274. Vieyra Garcia P, Wei T, Naym D, Fredholm S, Fink Puches R, Cerroni L, et al. STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides. Clin Cancer Res. 2016;22:3328-39 pubmed 出版商
  275. Ophelders D, Gussenhoven R, Lammens M, Küsters B, Kemp M, Newnham J, et al. Neuroinflammation and structural injury of the fetal ovine brain following intra-amniotic Candida albicans exposure. J Neuroinflammation. 2016;13:29 pubmed 出版商
  276. Veazey R, Pilch Cooper H, Hope T, Alter G, Carias A, Sips M, et al. Prevention of SHIV transmission by topical IFN-β treatment. Mucosal Immunol. 2016;9:1528-1536 pubmed 出版商
  277. Cao Y, Amezquita R, Kleinstein S, Stathopoulos P, Nowak R, O Connor K. Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-γ, and GM-CSF and Diminished IL-10 Production. J Immunol. 2016;196:2075-84 pubmed 出版商
  278. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed 出版商
  279. Li L, Jiang Y, Lao S, Yang B, Yu S, Zhang Y, et al. Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12. PLoS ONE. 2016;11:e0147356 pubmed 出版商
  280. Di Meglio P, Villanova F, Navarini A, Mylonas A, Tosi I, Nestle F, et al. Targeting CD8(+) T cells prevents psoriasis development. J Allergy Clin Immunol. 2016;138:274-276.e6 pubmed 出版商
  281. Allaire J, Roy S, Ouellet C, Lemieux Ã, Jones C, Paquet M, et al. Bmp signaling in colonic mesenchyme regulates stromal microenvironment and protects from polyposis initiation. Int J Cancer. 2016;138:2700-12 pubmed 出版商
  282. Vargas Inchaustegui D, Demers A, Shaw J, Kang G, Ball D, Tuero I, et al. Vaccine Induction of Lymph Node-Resident Simian Immunodeficiency Virus Env-Specific T Follicular Helper Cells in Rhesus Macaques. J Immunol. 2016;196:1700-10 pubmed 出版商
  283. Soh K, Tario J, Colligan S, Maguire O, Pan D, Minderman H, et al. Simultaneous, Single-Cell Measurement of Messenger RNA, Cell Surface Proteins, and Intracellular Proteins. Curr Protoc Cytom. 2016;75:7.45.1-7.45.33 pubmed 出版商
  284. Rothermel L, Sabesan A, Stephens D, Chandran S, Paria B, Srivastava A, et al. Identification of an Immunogenic Subset of Metastatic Uveal Melanoma. Clin Cancer Res. 2016;22:2237-49 pubmed 出版商
  285. Paris R, Petrovas C, Ferrando Martinez S, Moysi E, Boswell K, Archer E, et al. Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression. PLoS ONE. 2015;10:e0144767 pubmed 出版商
  286. Scholz A, Harter P, Cremer S, Yalcin B, Gurnik S, Yamaji M, et al. Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma. EMBO Mol Med. 2016;8:39-57 pubmed 出版商
  287. Lee W, Richard J, Lichtfuss M, Smith A, Park J, Courter J, et al. Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells. J Virol. 2016;90:2021-30 pubmed 出版商
  288. Panousis C, Dhagat U, Edwards K, Rayzman V, Hardy M, Braley H, et al. CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors. MAbs. 2016;8:436-53 pubmed 出版商
  289. Zhang N, Deng J, Wu F, Lu X, Huang L, Zhao M. Expression of arginase I and inducible nitric oxide synthase in the peripheral blood and lymph nodes of HIV‑positive patients. Mol Med Rep. 2016;13:731-43 pubmed 出版商
  290. Woodfolk J, Glesner J, Wright P, Kepley C, Li M, Himly M, et al. Antigenic Determinants of the Bilobal Cockroach Allergen Bla g 2. J Biol Chem. 2016;291:2288-301 pubmed 出版商
  291. Ashraf M, Schwelberger H, Brendel K, Feurle J, Andrassy J, Kotsch K, et al. Exogenous Lipocalin 2 Ameliorates Acute Rejection in a Mouse Model of Renal Transplantation. Am J Transplant. 2016;16:808-20 pubmed 出版商
  292. Bolton D, Pegu A, Wang K, McGinnis K, Nason M, Foulds K, et al. Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs. J Virol. 2016;90:1321-32 pubmed 出版商
  293. Langer S, Hopfensperger K, Iyer S, Kreider E, Learn G, Lee L, et al. A Naturally Occurring rev1-vpu Fusion Gene Does Not Confer a Fitness Advantage to HIV-1. PLoS ONE. 2015;10:e0142118 pubmed 出版商
  294. Vierboom M, Breedveld E, Kap Y, Mary C, Poirier N, t Hart B, et al. Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis. Clin Exp Immunol. 2016;183:405-18 pubmed 出版商
  295. Zhao E, Maj T, Kryczek I, Li W, Wu K, Zhao L, et al. Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. Nat Immunol. 2016;17:95-103 pubmed 出版商
  296. Deisting W, Raum T, Kufer P, Baeuerle P, Münz M. Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110. PLoS ONE. 2015;10:e0141669 pubmed 出版商
  297. van Nierop G, Janssen M, Mitterreiter J, van de Vijver D, De Swart R, Haagmans B, et al. Intrathecal CD4(+) and CD8(+) T-cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients. Eur J Immunol. 2016;46:347-53 pubmed 出版商
  298. Oh Y, Park H, Shin J, Lee J, Park H, Kho D, et al. Ndrg1 is a T-cell clonal anergy factor negatively regulated by CD28 costimulation and interleukin-2. Nat Commun. 2015;6:8698 pubmed 出版商
  299. Cox K, Tang A, Chen Z, Horton M, Yan H, Wang X, et al. Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell cultures. MAbs. 2016;8:129-40 pubmed 出版商
  300. Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015;7:310ra166 pubmed 出版商
  301. Miles B, Miller S, Folkvord J, Kimball A, Chamanian M, Meditz A, et al. Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection. Nat Commun. 2015;6:8608 pubmed 出版商
  302. Newell K, Asare A, Sanz I, Wei C, Rosenberg A, Gao Z, et al. Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients. Am J Transplant. 2015;15:2908-20 pubmed 出版商
  303. Heigele A, Joas S, Regensburger K, Kirchhoff F. Increased susceptibility of CD4+ T cells from elderly individuals to HIV-1 infection and apoptosis is associated with reduced CD4 and enhanced CXCR4 and FAS surface expression levels. Retrovirology. 2015;12:86 pubmed 出版商
  304. Monahan R, Stein A, Gibbs K, Bank M, Bloom O. Circulating T cell subsets are altered in individuals with chronic spinal cord injury. Immunol Res. 2015;63:3-10 pubmed 出版商
  305. Gao Y, Zhang M, Li J, Yang M, Liu Y, Guo X, et al. Circulating FoxP3+ Regulatory T and Interleukin17-Producing Th17 Cells Actively Influence HBV Clearance in De Novo Hepatitis B Virus Infected Patients after Orthotopic Liver Transplantation. PLoS ONE. 2015;10:e0137881 pubmed 出版商
  306. Campi Azevedo A, Costa Pereira C, Antonelli L, Fonseca C, Teixeira Carvalho A, Villela Rezende G, et al. Booster dose after 10 years is recommended following 17DD-YF primary vaccination. Hum Vaccin Immunother. 2016;12:491-502 pubmed 出版商
  307. Ribera Cortada I, Martinez D, Amador V, Royo C, Navarro A, Beà S, et al. Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype. Mod Pathol. 2015;28:1435-47 pubmed 出版商
  308. Loyer X, Paradis V, Hénique C, Vion A, Colnot N, Guerin C, et al. Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression. Gut. 2016;65:1882-1894 pubmed 出版商
  309. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed 出版商
  310. Zhang W, Smythe J, Frith E, Belfield H, Clarke S, Watt S, et al. An innovative method to generate a Good Manufacturing Practice-ready regulatory T-cell product from non-mobilized leukapheresis donors. Cytotherapy. 2015;17:1268-79 pubmed 出版商
  311. Dunham J, Lee L, van Driel N, Laman J, Ni I, Zhai W, et al. Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis. J Neuroimmune Pharmacol. 2016;11:73-83 pubmed 出版商
  312. Evans T, Li H, Schafer J, Klatt N, Hao X, Traslavina R, et al. SIV-induced Translocation of Bacterial Products in the Liver Mobilizes Myeloid Dendritic and Natural Killer Cells Associated With Liver Damage. J Infect Dis. 2016;213:361-9 pubmed 出版商
  313. Riou C, Tanko R, Soares A, Masson L, Werner L, Garrett N, et al. Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype. J Immunol. 2015;195:2273-2281 pubmed 出版商
  314. Amos J, Himes J, Armand L, Gurley T, Martinez D, Colvin L, et al. Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys. J Virol. 2015;89:9485-98 pubmed 出版商
  315. Chalan P, Bijzet J, Huitema M, Kroesen B, Brouwer E, Boots A. Expression of Lectin-Like Transcript 1, the Ligand for CD161, in Rheumatoid Arthritis. PLoS ONE. 2015;10:e0132436 pubmed 出版商
  316. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed 出版商
  317. Mikucki M, Fisher D, Matsuzaki J, Skitzki J, Gaulin N, Muhitch J, et al. Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints. Nat Commun. 2015;6:7458 pubmed 出版商
  318. Stenger E, Chiang K, Haight A, Qayed M, Kean L, Horan J. Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases. Biol Blood Marrow Transplant. 2015;21:1845-52 pubmed 出版商
  319. Cimini E, Agrati C, D Offizi G, Vlassi C, Casetti R, Sacchi A, et al. Primary and Chronic HIV Infection Differently Modulates Mucosal Vδ1 and Vδ2 T-Cells Differentiation Profile and Effector Functions. PLoS ONE. 2015;10:e0129771 pubmed 出版商
  320. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed 出版商
  321. Larsson K, Kock A, Idborg H, Arsenian Henriksson M, Martinsson T, Johnsen J, et al. COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset. Proc Natl Acad Sci U S A. 2015;112:8070-5 pubmed 出版商
  322. Chowdhury A, Hayes T, Bosinger S, Lawson B, Vanderford T, Schmitz J, et al. Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques. J Virol. 2015;89:8677-86 pubmed 出版商
  323. Soares A, Müller T, Chege G, Williamson A, Burgers W. Transient global T cell activation after vaccination of rhesus macaques with a DNA-poxvirus vaccine regimen for HIV. Vaccine. 2015;33:3435-9 pubmed 出版商
  324. Mathur R, Sehgal L, Braun F, Berkova Z, Romaguerra J, Wang M, et al. Targeting Wnt pathway in mantle cell lymphoma-initiating cells. J Hematol Oncol. 2015;8:63 pubmed 出版商
  325. Kerkman P, Fabre E, van der Voort E, Zaldumbide A, Rombouts Y, Rispens T, et al. Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritis. Ann Rheum Dis. 2016;75:1170-6 pubmed 出版商
  326. Boisson B, Laplantine E, Dobbs K, Cobat A, Tarantino N, Hazen M, et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J Exp Med. 2015;212:939-51 pubmed 出版商
  327. McCully M, Collins P, Hughes T, Thomas C, Billen J, O Donnell V, et al. Skin Metabolites Define a New Paradigm in the Localization of Skin Tropic Memory T Cells. J Immunol. 2015;195:96-104 pubmed 出版商
  328. Vettermann C, Victor H, Sun Y, Plewa C, Gupta S. A signaling-enhanced chimeric receptor to activate the ICOS pathway in T cells. J Immunol Methods. 2015;424:14-9 pubmed 出版商
  329. Zhou H, Martínez H, Sun B, Li A, Zimmer M, Katsanis N, et al. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood. Stem Cell Rev. 2015;11:652-65 pubmed 出版商
  330. Byrareddy S, Sidell N, Arthos J, Cicala C, Zhao C, Little D, et al. Species-specific differences in the expression and regulation of α4β7 integrin in various nonhuman primates. J Immunol. 2015;194:5968-79 pubmed 出版商
  331. Thiault N, Darrigues J, Adoue V, Gros M, Binet B, Pérals C, et al. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat Immunol. 2015;16:628-34 pubmed 出版商
  332. Kinder M, Greenplate A, Strohl W, Jordan R, Brezski R. An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions. MAbs. 2015;7:494-504 pubmed 出版商
  333. Takata K, Noujima Harada M, Miyata Takata T, Ichimura K, Sato Y, Miyata T, et al. Clinicopathologic analysis of 6 lymphomatoid gastropathy cases: expanding the disease spectrum to CD4-CD8+ cases. Am J Surg Pathol. 2015;39:1259-66 pubmed 出版商
  334. DaFonseca S, Niessl J, Pouvreau S, Wacleche V, Gosselin A, Cleret Buhot A, et al. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. Retrovirology. 2015;12:38 pubmed 出版商
  335. Lenz N, Schindler T, Kagina B, Zhang J, Lukindo T, Mpina M, et al. Antiviral Innate Immune Activation in HIV-Infected Adults Negatively Affects H1/IC31-Induced Vaccine-Specific Memory CD4+ T Cells. Clin Vaccine Immunol. 2015;22:688-96 pubmed 出版商
  336. Anandasabapathy N, Breton G, Hurley A, Caskey M, Trumpfheller C, Sarma P, et al. Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers. Bone Marrow Transplant. 2015;50:924-30 pubmed 出版商
  337. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed 出版商
  338. Metcalf Pate K, Pohlmeyer C, Walker Sperling V, Foote J, Najarro K, Cryer C, et al. A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads. J Infect Dis. 2015;212:1387-96 pubmed 出版商
  339. Zhou J, Amran F, Kramski M, Angelovich T, Elliott J, Hearps A, et al. An NK Cell Population Lacking FcRγ Is Expanded in Chronically Infected HIV Patients. J Immunol. 2015;194:4688-97 pubmed 出版商
  340. Boerman G, van Ostaijen Ten Dam M, Kraal K, Santos S, Ball L, Lankester A, et al. Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells. Cancer Immunol Immunother. 2015;64:573-83 pubmed 出版商
  341. Yukl S, Shergill A, Girling V, Li Q, Killian M, Epling L, et al. Site-specific differences in T cell frequencies and phenotypes in the blood and gut of HIV-uninfected and ART-treated HIV+ adults. PLoS ONE. 2015;10:e0121290 pubmed 出版商
  342. Hong M, Sandalova E, Low D, Gehring A, Fieni S, Amadei B, et al. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588 pubmed 出版商
  343. Ohnuma K, Hatano R, Aune T, Otsuka H, Iwata S, Dang N, et al. Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes. J Immunol. 2015;194:3697-712 pubmed 出版商
  344. Strick Marchand H, Dusséaux M, Darche S, Huntington N, Legrand N, Masse Ranson G, et al. A novel mouse model for stable engraftment of a human immune system and human hepatocytes. PLoS ONE. 2015;10:e0119820 pubmed 出版商
  345. Chen M, Hu P, Ling N, Peng H, Lei Y, Hu H, et al. Enhanced functions of peripheral γδ T cells in chronic hepatitis B infection during interferon α treatment in vivo and in vitro. PLoS ONE. 2015;10:e0120086 pubmed 出版商
  346. Bowcutt R, Malter L, Chen L, Wolff M, Robertson I, Rifkin D, et al. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon. J Immunol Methods. 2015;421:27-35 pubmed 出版商
  347. Nambiar J, Clarke A, Shim D, Mabon D, Tian C, Windloch K, et al. Potent neutralizing anti-CD1d antibody reduces lung cytokine release in primate asthma model. MAbs. 2015;7:638-50 pubmed 出版商
  348. Martínez Torres A, Quiney C, Attout T, Boullet H, Herbi L, Vela L, et al. CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans. PLoS Med. 2015;12:e1001796 pubmed 出版商
  349. Meykler S, Baloch Z, Barroeta J. A case of marginal zone lymphoma with extensive emperipolesis diagnosed on pleural effusion cytology with immunocytochemistry and flow cytometry. Cytopathology. 2016;27:70-2 pubmed 出版商
  350. Boyle M, Jagannathan P, Bowen K, McIntyre T, Vance H, Farrington L, et al. Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations. J Infect Dis. 2015;212:416-25 pubmed 出版商
  351. Lehnhardt A, Strecker M, Eiermann T, Marget M, Thaiss F, Nashan B, et al. High B-cell activating factor is not associated with worse 3-year graft outcome in blood group-incompatible kidney transplantation with rituximab induction. Clin Transplant. 2015;29:359-64 pubmed 出版商
  352. Gideon H, Phuah J, Myers A, Bryson B, Rodgers M, Coleman M, et al. Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization. PLoS Pathog. 2015;11:e1004603 pubmed 出版商
  353. Khan A, Srivastava R, Spencer D, Garg S, Fremgen D, Vahed H, et al. Phenotypic and functional characterization of herpes simplex virus glycoprotein B epitope-specific effector and memory CD8+ T cells from symptomatic and asymptomatic individuals with ocular herpes. J Virol. 2015;89:3776-92 pubmed 出版商
  354. Johnson P, Challis R, Chowdhury F, Gao Y, Harvey M, Geldart T, et al. Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study. Clin Cancer Res. 2015;21:1321-8 pubmed 出版商
  355. Yu A, Snowhite I, Vendrame F, Rosenzwajg M, Klatzmann D, Pugliese A, et al. Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes. Diabetes. 2015;64:2172-83 pubmed 出版商
  356. Afshar M, Richards S, Mann D, Cross A, Smith G, Netzer G, et al. Acute immunomodulatory effects of binge alcohol ingestion. Alcohol. 2015;49:57-64 pubmed 出版商
  357. Bigley V, McGovern N, Milne P, Dickinson R, Pagan S, Cookson S, et al. Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells. J Leukoc Biol. 2015;97:627-34 pubmed 出版商
  358. Nemes E, Kagina B, Smit E, Africa H, Steyn M, Hanekom W, et al. Differential leukocyte counting and immunophenotyping in cryopreserved ex vivo whole blood. Cytometry A. 2015;87:157-65 pubmed 出版商
  359. Konadu K, Chu J, Huang M, Amancha P, Armstrong W, Powell M, et al. Association of Cytokines With Exosomes in the Plasma of HIV-1-Seropositive Individuals. J Infect Dis. 2015;211:1712-6 pubmed 出版商
  360. Heninger A, Wentrup S, Al Saeedi M, Schiessling S, Giese T, Wartha F, et al. Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®. Immun Inflamm Dis. 2014;2:166-80 pubmed 出版商
  361. Campbell J, Ratai E, Autissier P, Nolan D, Tse S, Miller A, et al. Anti-?4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infection. PLoS Pathog. 2014;10:e1004533 pubmed 出版商
  362. Woda M, Mathew A. Fluorescently labeled dengue viruses as probes to identify antigen-specific memory B cells by multiparametric flow cytometry. J Immunol Methods. 2015;416:167-77 pubmed 出版商
  363. Li H, Evans T, Gillis J, Connole M, Reeves R. Bone marrow-imprinted gut-homing of plasmacytoid dendritic cells (pDCs) in acute simian immunodeficiency virus infection results in massive accumulation of hyperfunctional CD4+ pDCs in the mucosae. J Infect Dis. 2015;211:1717-25 pubmed 出版商
  364. Weihrauch M, Richly H, von Bergwelt Baildon M, Becker H, Schmidt M, Hacker U, et al. Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. Eur J Cancer. 2015;51:146-56 pubmed 出版商
  365. Setoguchi R, Matsui Y, Mouri K. mTOR signaling promotes a robust and continuous production of IFN-γ by human memory CD8+ T cells and their proliferation. Eur J Immunol. 2015;45:893-902 pubmed 出版商
  366. Chacon J, Sarnaik A, Chen J, Creasy C, Kale C, Robinson J, et al. Manipulating the tumor microenvironment ex vivo for enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy. Clin Cancer Res. 2015;21:611-21 pubmed 出版商
  367. Bell C, Sun Y, Nowak U, Clark J, Howlett S, Pekalski M, et al. Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells. J Autoimmun. 2015;56:66-80 pubmed 出版商
  368. Crompton J, Sukumar M, Roychoudhuri R, Clever D, Gros A, Eil R, et al. Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics. Cancer Res. 2015;75:296-305 pubmed 出版商
  369. Stacchini A, Pacchioni D, Demurtas A, Aliberti S, Cassenti A, Isolato G, et al. Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas. Cytometry B Clin Cytom. 2015;88:320-9 pubmed 出版商
  370. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed 出版商
  371. Dominguez Villar M, Gautron A, de Marcken M, Keller M, Hafler D. TLR7 induces anergy in human CD4(+) T cells. Nat Immunol. 2015;16:118-28 pubmed 出版商
  372. Vogelpoel L, Hansen I, Rispens T, Muller F, van Capel T, Turina M, et al. Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages. Nat Commun. 2014;5:5444 pubmed 出版商
  373. Makowski S, Wang Z, Pomerantz J. A protease-independent function for SPPL3 in NFAT activation. Mol Cell Biol. 2015;35:451-67 pubmed 出版商
  374. Thompson I, Mann E, Stokes M, English N, Knight S, Williamson D. Specific activation of dendritic cells enhances clearance of Bacillus anthracis following infection. PLoS ONE. 2014;9:e109720 pubmed 出版商
  375. Fujita T, Burwitz B, Chew G, Reed J, Pathak R, Seger E, et al. Expansion of dysfunctional Tim-3-expressing effector memory CD8+ T cells during simian immunodeficiency virus infection in rhesus macaques. J Immunol. 2014;193:5576-83 pubmed 出版商
  376. Neumann B, Klippert A, Raue K, Sopper S, Stahl Hennig C. Characterization of B and plasma cells in blood, bone marrow, and secondary lymphoid organs of rhesus macaques by multicolor flow cytometry. J Leukoc Biol. 2015;97:19-30 pubmed 出版商
  377. Luetke Eversloh M, Hammer Q, Durek P, Nordström K, Gasparoni G, Pink M, et al. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog. 2014;10:e1004441 pubmed 出版商
  378. Weed D, Vella J, Reis I, De La Fuente A, Gomez C, Sargi Z, et al. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma. Clin Cancer Res. 2015;21:39-48 pubmed 出版商
  379. Weiskopf D, Angelo M, Bangs D, Sidney J, Paul S, Peters B, et al. The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes. J Virol. 2015;89:120-8 pubmed 出版商
  380. Lim D, Yawata N, Selva K, Li N, Tsai C, Yeong L, et al. The combination of type I IFN, TNF-α, and cell surface receptor engagement with dendritic cells enables NK cells to overcome immune evasion by dengue virus. J Immunol. 2014;193:5065-75 pubmed 出版商
  381. Wilson E, Bial J, Tarlow B, Bial G, Jensen B, Greiner D, et al. Extensive double humanization of both liver and hematopoiesis in FRGN mice. Stem Cell Res. 2014;13:404-12 pubmed 出版商
  382. Maney N, Reynolds G, Krippner Heidenreich A, Hilkens C. Dendritic cell maturation and survival are differentially regulated by TNFR1 and TNFR2. J Immunol. 2014;193:4914-4923 pubmed 出版商
  383. Spaan M, Kreefft K, de Graav G, Brouwer W, de Knegt R, ten Kate F, et al. CD4+ CXCR5+ T cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B cell responses. J Hepatol. 2015;62:303-10 pubmed 出版商
  384. Alnabhan R, Madrigal A, Saudemont A. Differential activation of cord blood and peripheral blood natural killer cells by cytokines. Cytotherapy. 2015;17:73-85 pubmed 出版商
  385. Yu C, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol. 2014;193:4335-43 pubmed 出版商
  386. Mylvaganam G, Velu V, Hong J, Sadagopal S, Kwa S, Basu R, et al. Diminished viral control during simian immunodeficiency virus infection is associated with aberrant PD-1hi CD4 T cell enrichment in the lymphoid follicles of the rectal mucosa. J Immunol. 2014;193:4527-36 pubmed 出版商
  387. Willis E, Eberle R, Wolf R, White G, McFarlane D. The effects of age and cytomegalovirus on markers of inflammation and lymphocyte populations in captive baboons. PLoS ONE. 2014;9:e107167 pubmed 出版商
  388. Rasmussen S, Bilgrau A, Schmitz A, Falgreen S, Bergkvist K, Tramm A, et al. Stable Phenotype Of B-Cell Subsets Following Cryopreservation and Thawing of Normal Human Lymphocytes Stored in a Tissue Biobank. Cytometry B Clin Cytom. 2014;: pubmed 出版商
  389. Kudernatsch R, Letsch A, Guerreiro M, Löbel M, Bauer S, Volk H, et al. Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity. Eur J Immunol. 2014;44:3532-42 pubmed 出版商
  390. Valentin A, McKinnon K, Li J, Rosati M, Kulkarni V, Pilkington G, et al. Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaques. Clin Immunol. 2014;155:91-107 pubmed 出版商
  391. Perreau M, Vigano S, Bellanger F, Pellaton C, Buss G, Comte D, et al. Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders. J Exp Med. 2014;211:2033-45 pubmed 出版商
  392. Kurktschiev P, Raziorrouh B, Schraut W, Backmund M, Wächtler M, Wendtner C, et al. Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction. J Exp Med. 2014;211:2047-59 pubmed 出版商
  393. Landy J, Al Hassi H, Ronde E, English N, Mann E, Bernardo D, et al. Innate immune factors in the development and maintenance of pouchitis. Inflamm Bowel Dis. 2014;20:1942-9 pubmed 出版商
  394. Kagina B, Tameris M, Geldenhuys H, Hatherill M, Abel B, Hussey G, et al. The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses. Vaccine. 2014;32:5908-17 pubmed 出版商
  395. Yu J, Zuo Z, Zhang W, Yang Q, Zhang Y, Tang Y, et al. Identification of immunophenotypic subtypes with different prognoses in extranodal natural killer/T-cell lymphoma, nasal type. Hum Pathol. 2014;45:2255-62 pubmed 出版商
  396. Ezzelarab M, Ekser B, Azimzadeh A, Lin C, Zhao Y, Rodriguez R, et al. Systemic inflammation in xenograft recipients precedes activation of coagulation. Xenotransplantation. 2015;22:32-47 pubmed 出版商
  397. Hu H, Eller M, Zafar S, Zhou Y, Gu M, Wei Z, et al. Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals. Proc Natl Acad Sci U S A. 2014;111:13439-44 pubmed 出版商
  398. Toapanta F, Simon J, Barry E, Pasetti M, Levine M, Kotloff K, et al. Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans. Front Immunol. 2014;5:374 pubmed 出版商
  399. Matsuda K, Dang Q, Brown C, Keele B, Wu F, Ourmanov I, et al. Characterization of simian immunodeficiency virus (SIV) that induces SIV encephalitis in rhesus macaques with high frequency: role of TRIM5 and major histocompatibility complex genotypes and early entry to the brain. J Virol. 2014;88:13201-11 pubmed 出版商
  400. Del Prete G, Shoemaker R, Oswald K, Lara A, Trubey C, Fast R, et al. Effect of suberoylanilide hydroxamic acid (SAHA) administration on the residual virus pool in a model of combination antiretroviral therapy-mediated suppression in SIVmac239-infected indian rhesus macaques. Antimicrob Agents Chemother. 2014;58:6790-806 pubmed 出版商
  401. Chao Y, Kaliaperumal N, Chretien A, Tang S, Lee B, Poidinger M, et al. Human plasmacytoid dendritic cells regulate IFN-α production through activation-induced splicing of IL-18Rα. J Leukoc Biol. 2014;96:1037-46 pubmed 出版商
  402. Madhavi V, Ana Sosa Batiz F, Jegaskanda S, Center R, Winnall W, Parsons M, et al. Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy. J Infect Dis. 2015;211:529-38 pubmed 出版商
  403. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed 出版商
  404. Kreiser S, Eckhardt J, Kuhnt C, Stein M, Krzyzak L, Seitz C, et al. Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo. Immunobiology. 2015;220:270-9 pubmed 出版商
  405. Ohue Y, Kurose K, Mizote Y, Matsumoto H, Nishio Y, Isobe M, et al. Prolongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibody. Clin Cancer Res. 2014;20:5052-63 pubmed 出版商
  406. Bending D, Pesenacker A, Ursu S, Wu Q, Lom H, Thirugnanabalan B, et al. Hypomethylation at the regulatory T cell-specific demethylated region in CD25hi T cells is decoupled from FOXP3 expression at the inflamed site in childhood arthritis. J Immunol. 2014;193:2699-708 pubmed 出版商
  407. Arlehamn C, Seumois G, Gerasimova A, Huang C, Fu Z, Yue X, et al. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J Immunol. 2014;193:2931-40 pubmed 出版商
  408. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed 出版商
  409. Buggert M, Tauriainen J, Yamamoto T, Frederiksen J, Ivarsson M, Michaelsson J, et al. T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection. PLoS Pathog. 2014;10:e1004251 pubmed 出版商
  410. Kawasaki N, Rillahan C, Cheng T, Van Rhijn I, Macauley M, Moody D, et al. Targeted delivery of mycobacterial antigens to human dendritic cells via Siglec-7 induces robust T cell activation. J Immunol. 2014;193:1560-6 pubmed 出版商
  411. Jacquelin B, Petitjean G, Kunkel D, Liovat A, Jochems S, Rogers K, et al. Innate immune responses and rapid control of inflammation in African green monkeys treated or not with interferon-alpha during primary SIVagm infection. PLoS Pathog. 2014;10:e1004241 pubmed 出版商
  412. Gomez A, Willcox N, Vrolix K, Hummel J, Nogales Gadea G, Saxena A, et al. Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients. J Immunol. 2014;193:1055-1063 pubmed 出版商
  413. Lepore M, de Lalla C, Gundimeda S, Gsellinger H, Consonni M, Garavaglia C, et al. A novel self-lipid antigen targets human T cells against CD1c(+) leukemias. J Exp Med. 2014;211:1363-77 pubmed 出版商
  414. Gupta M, Kolli D, Molteni C, Casola A, Garofalo R. Paramyxovirus infection regulates T cell responses by BDCA-1+ and BDCA-3+ myeloid dendritic cells. PLoS ONE. 2014;9:e99227 pubmed 出版商
  415. Steinsbø Ø, Henry Dunand C, Huang M, Mesin L, Salgado Ferrer M, Lundin K, et al. Restricted VH/VL usage and limited mutations in gluten-specific IgA of coeliac disease lesion plasma cells. Nat Commun. 2014;5:4041 pubmed 出版商
  416. Hong J, Amancha P, Rogers K, Courtney C, Havenar Daughton C, Crotty S, et al. Early lymphoid responses and germinal center formation correlate with lower viral load set points and better prognosis of simian immunodeficiency virus infection. J Immunol. 2014;193:797-806 pubmed 出版商
  417. Payne T, Blackinton J, Frisbee A, Pickeral J, Sawant S, Vandergrift N, et al. Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition. J Virol. 2014;88:9514-28 pubmed 出版商
  418. Watanabe M, Kudo Y, Kawano M, Nakayama M, Nakamura K, Kameda M, et al. NKG2D functions as an activating receptor on natural killer cells in the common marmoset (Callithrix jacchus). Int Immunol. 2014;26:597-606 pubmed 出版商
  419. Demberg T, Mohanram V, Venzon D, Robert Guroff M. Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model. Clin Immunol. 2014;153:264-76 pubmed 出版商
  420. Vargas A, Zhou S, Ethier Chiasson M, Flipo D, Lafond J, Gilbert C, et al. Syncytin proteins incorporated in placenta exosomes are important for cell uptake and show variation in abundance in serum exosomes from patients with preeclampsia. FASEB J. 2014;28:3703-19 pubmed 出版商
  421. Barbosa R, Silva S, Silva S, Melo A, Pereira Santos M, Barata J, et al. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency. J Clin Immunol. 2014;34:573-83 pubmed 出版商
  422. Buggert M, Norstr m M, Salemi M, Hecht F, Karlsson A. Functional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progression. J Immunol. 2014;192:4685-96 pubmed 出版商
  423. Okimura K, Maeta K, Kobayashi N, Goto M, Kano N, Ishihara T, et al. Characterization of ASKP1240, a fully human antibody targeting human CD40 with potent immunosuppressive effects. Am J Transplant. 2014;14:1290-9 pubmed 出版商
  424. Itoua Maïga R, Lemieux J, Roy A, Simard C, Néron S. Flow cytometry assessment of in vitro generated CD138+ human plasma cells. Biomed Res Int. 2014;2014:536482 pubmed 出版商
  425. Gros A, Robbins P, Yao X, Li Y, Turcotte S, Tran E, et al. PD-1 identifies the patient-specific CD8? tumor-reactive repertoire infiltrating human tumors. J Clin Invest. 2014;124:2246-59 pubmed 出版商
  426. Hodara V, Parodi L, Chavez D, Smith L, Lanford R, Giavedoni L. Characterization of ??T cells in naïve and HIV-infected chimpanzees and their responses to T-cell activators in vitro. J Med Primatol. 2014;43:258-71 pubmed 出版商
  427. Prinz P, Mendler A, Brech D, Masouris I, Oberneder R, Noessner E. NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention. Int J Cancer. 2014;135:1832-41 pubmed 出版商
  428. de Hair M, van de Sande M, Ramwadhdoebe T, Hansson M, Landewe R, van der Leij C, et al. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol. 2014;66:513-22 pubmed 出版商
  429. Rodriguez A, Hodara V, Murthy K, Morrow L, Sanchez M, Bienvenu A, et al. T cell interleukin-15 surface expression in chimpanzees infected with human immunodeficiency virus. Cell Immunol. 2014;288:24-30 pubmed 出版商
  430. Poonia B, Pauza C. Levels of CD56+TIM-3- effector CD8 T cells distinguish HIV natural virus suppressors from patients receiving antiretroviral therapy. PLoS ONE. 2014;9:e88884 pubmed 出版商
  431. Wertheimer A, Bennett M, Park B, Uhrlaub J, Martinez C, Pulko V, et al. Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J Immunol. 2014;192:2143-55 pubmed 出版商
  432. Kulkarni V, Valentin A, Rosati M, Alicea C, Singh A, Jalah R, et al. Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques. PLoS ONE. 2014;9:e86254 pubmed 出版商
  433. Crawford T, Jalbert E, Ndhlovu L, Barbour J. Concomitant evaluation of PMA+ionomycin-induced kinase phosphorylation and cytokine production in T cell subsets by flow cytometry. Cytometry A. 2014;85:268-76 pubmed 出版商
  434. Guan S, Liu J, Fang E, Ng T, Lian Y, Ge H. Chronic unpredictable mild stress impairs erythrocyte immune function and changes T-lymphocyte subsets in a rat model of stress-induced depression. Environ Toxicol Pharmacol. 2014;37:414-22 pubmed 出版商
  435. Doi H, Tanoue S, Kaplan D. Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis. Clin Immunol. 2014;150:184-91 pubmed 出版商
  436. Kim H, Lee H, Chang Y, Pichavant M, Shore S, Fitzgerald K, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med. 2014;20:54-61 pubmed 出版商
  437. Cairo C, Longinaker N, Cappelli G, Leke R, Ondo M, Djokam R, et al. Cord blood V?2V?2 T cells provide a molecular marker for the influence of pregnancy-associated malaria on neonatal immunity. J Infect Dis. 2014;209:1653-62 pubmed 出版商
  438. Turcotte S, Gros A, Tran E, Lee C, Wunderlich J, Robbins P, et al. Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy. Clin Cancer Res. 2014;20:331-43 pubmed 出版商
  439. Han J, Rho S, Lee J, Bae J, Park S, Lee S, et al. Human cytomegalovirus (HCMV) US2 protein interacts with human CD1d (hCD1d) and down-regulates invariant NKT (iNKT) cell activity. Mol Cells. 2013;36:455-64 pubmed 出版商
  440. Krishnan S, Wilson E, Sheikh V, Rupert A, Mendoza D, Yang J, et al. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis. 2014;209:931-9 pubmed 出版商
  441. Stacchini A, Aliberti S, Pacchioni D, Demurtas A, Isolato G, Gazzera C, et al. Flow cytometry significantly improves the diagnostic value of fine needle aspiration cytology of lymphoproliferative lesions of salivary glands. Cytopathology. 2014;25:231-40 pubmed 出版商
  442. Ascierto M, Idowu M, Zhao Y, Khalak H, Payne K, Wang X, et al. Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients. J Transl Med. 2013;11:145 pubmed 出版商
  443. Li H, Pauza C. Critical roles for Akt kinase in controlling HIV envelope-mediated depletion of CD4 T cells. Retrovirology. 2013;10:60 pubmed 出版商
  444. Melis L, Van Praet L, Pircher H, Venken K, Elewaut D. Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-? production by interaction with its soluble E-cadherin ligand in chronically inflamed joints. Ann Rheum Dis. 2014;73:1223-31 pubmed 出版商
  445. Liu J, Glosson N, Du W, Gervay Hague J, Brutkiewicz R. A Thr/Ser dual residue motif in the cytoplasmic tail of human CD1d is important for the down-regulation of antigen presentation following a herpes simplex virus 1 infection. Immunology. 2013;140:191-201 pubmed 出版商
  446. Greig B, Stetler Stevenson M, Lea J. Stabilization media increases recovery in paucicellular cerebrospinal fluid specimens submitted for flow cytometry testing. Cytometry B Clin Cytom. 2014;86:135-8 pubmed 出版商
  447. Jacobs S, Plessers J, Pinxteren J, Roobrouck V, Verfaillie C, Van Gool S. Mutual interaction between human multipotent adult progenitor cells and NK cells. Cell Transplant. 2014;23:1099-110 pubmed 出版商
  448. Brana C, Frossard M, Pescini Gobert R, Martinier N, Boschert U, Seabrook T. Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions. Neuropathol Appl Neurobiol. 2014;40:564-78 pubmed 出版商
  449. Gurer C, Strowig T, Brilot F, Pack M, Trumpfheller C, Arrey F, et al. Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood. 2008;112:1231-9 pubmed 出版商
  450. Contamin H, Loizon S, Bourreau E, Michel J, Garraud O, Mercereau Puijalon O, et al. Flow cytometry identification and characterization of mononuclear cell subsets in the neotropical primate Saimiri sciureus (squirrel monkey). J Immunol Methods. 2005;297:61-71 pubmed